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Shiga toxin-producing Escherichia coli (STEC) are worldwide pathogens causing
an estimated 200,000 infections per year in the United States. Infections with STEC

sometimes progress to kidney failure ending in death. Two studies presented below
describe a novel virulence factor and mechanisms required for pathogenesis of STEC
seropathotype 091 :H21.

First the novel protein, YghJ, was identified and found to be conserved amongst
extraintestinal and diarrheal seropathotypes of E. coli with similar proteins carried by

pathogens such as Vibrio cholerae. When the yghJ gene was disrupted creating a YghJ
null mutant, the defect resulted in a significant growth deficiency in minimal media with

L-malate as the sole carbon source. The null mutant growth defect was complemented by

replacement of the mutated copy with an intact copy ofyghJ expressed from a high copy
number plasmid. Structure-function analysis of YghJ revealed lipidation restricts the
YghJ protein to the inner membrane. Further studies suggest an amino-terminal domain

involved in carbon binding and a carboxy-terminal region with mucinase activity. Taken
together, the data indicates that YghJ belongs to a new class of protein and plays an

important role in carbon utilization since oxidation of L-malate to oxaloacetate is

obligatory for survival of facultative anaerobes like E. coli.
The second study focused on regulation of expression of the enterohemolysin
toxin gene (ehxA) carried by STEC. The role of the HNS protein, a global inhibitor, was
investigated. Insertional mutation of the hns gene was constructed in STEC 091:H21and

revealed that the amount of EhxA increased in the hns knockout strain. The HNS protein
was found to control expression of the ehxA gene through direct binding of the promoter
upstream of the enterohemolysin operon (ehxCABD). In total, the data indicates that in
STEC the 88 bp DNA region upstream of e/urCABD contains a cis-acting element to

which HNS binds and negatively regulates expression of enterohemolysin.
In conclusion, YghJ participates in a key carbon metabolic pathway and provides

a competitive advantage in carbon-limited environments where L-malate is present.
Compelling evidence suggests that HNS interferes with RNA polymerase binding
blocking transcription of e/zxCABD in STEC grown ex vivo.

2010 Miles T.Rogers
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INTRODUCTION
Escherichia coli and its Environments

Escherichia coli are Gram-negative rod shaped facultative anaerobic bacteria that

adapt and live in a variety of settings. For example, E. coli have been isolated from the
environment (Nautiyal et al., 2010;Semenov et al., 2010) and non-pathogenic isolates of
E. coli exist in a mutualistic relationship with the mammalian host. Mutualistic E. coli

receive nutrients provided through metabolic cast-offs of the host and from by-products
of metabolites produced by other commensal bacteria that occupy the same niche within
the mammalian intestine (Dave et al., 2012). E. coli make-up less than 0.1% of the human

gut microbiome, in fact in the healthyhuman host, levels of E. coli are kept in check
(Dave et al., 2012). The relationship between the host and E. coli is complex and still
somewhat mysterious but we do know that E. coli produce vitamins and other metabolic

products required for human health (Drewke and Leistner, 2001;Moyne et al.,
2011;Preidisetal.,2011).

E. coli is not limited to the mammalian gastrointestinal tract but is capable of

survival on plants (Ibekwe et al., 2009;Ibekwe et al., 2011). For example, the pathogenic
Shiga toxin-producing E. coli (STEC) serotype 0157:H7 is able to survive and persist
after artificial inoculation on lettuce (Moyne et al., 2011). Further analysis reveals that E.
coli survive on the leaves of lettuce as well as in the root system of plants (rhizosphere)

(Ibekwe et al., 2009). Surprisingly, E. coli persist in environments irrigated by

contaminated water, suggesting a possible route of contamination (Ibekwe et al., 2004).

As we begin to move towards a more global food environment, persistence of pathogenic
E. coli becomes a larger issue, as seen by the increasing number of infections in the

developed and the developing world (Pires et al., 2009;Scallan et al., 2011). Notably the
2011 outbreak in Germany caused by fenugreek shoots contaminated by Shiga toxin-

producing E. coli serotype O104:H4 is an exampleof global food markets as a sourceof
contamination (European Food Safety Authority, 2011). The seeds were imported to
Germany from Egypt and the shoots served to customers resulted in one of the largest
and most lethal STEC outbreaks in Europe to date (European Food Safety Authority,
2011) (Kenny et al., 1997).

Seropathotypes of Escherichia coli

Different serogroups of is. coli are pathogenic (seropathotypes) and cause

infection by different mechanisms. Many seropathotypes of E. coli colonize the
gastrointestinal tract but some persist outside of the gut causing infection at other sites.
Depending on the niche in the host, seropathotypes of E. coli are extraintestinal
pathogenic E. coli (ExPEC) or urogenital pathogens (i.e. uropathogenic) E. coli (UPEC)
causing urinary tract infections (Patton et al. 1991). UPEC form biofilms and adhere to
uroepithelial cells of the urinary tract (Kikuchi et al., 2005) as well attach to indwelling
medical catheters (Jacobsen et al., 2008). Other ExPEC strains cause bacteremia leading
to sepsis or meningitis (Johnson and Russo, 2005).

A great deal is known about the intestinal pathogenic strains of E. coli but there
are still mechanisms of infection involved in pathogenesis that we do not yet understand.

Intestinal E. coli seropathotypes cause diarrheal disease through a variety of mechanisms
and toxins many times play a major role. Enterotoxigenic E. coli (ETEC) strains cause
travelers' diarrhea, are noninvasive and produce two toxins, a heat stable toxin and a

heat-labile toxin (Isidean et al., 2011). The Enteroaggregative seropathotype of E. coli

(EAEC) have a unique pattern of aggregation when attached to epithelial cells and
produce up to three toxins (Nataro et al., 1995). The EnteroinvasiveE. coli (EIEC) are
similar to Shigella because they actively invade and grow inside of host cells causing
intestinal epithelial cell death, watery diarrhea as well as a potent inflammatory response
described as dysentery (DuPont et al., 1971;Formal and Hornick, 1978). EIEC

seropathotypes produce a Shigella-like toxin but the role of the toxin in disease is unclear
(DuPont et al., 1971;Formal et al., 1978). Enteropathogenic E. coli (EPEC) causes
infantile diarrhea and is a severe problem in developing countries where good nutrition is

lacking. EPEC carry a large pathogenicity island required for intimate adherence to

human epithelial cells (Kenny et al., 1997). The adherence genes encoded by EPEC have
also been acquired by certain serotypes of Shiga toxin-producing E. coli.

Overview of Shiga Toxin-producing E. coli

Shiga toxin-producing E. coli (STEC) (Karmali et al., 1983a;Karmali et al.,
1983b) encode Shiga toxin and are the subject of this report. The Shiga toxin is a variant
of the Shigella toxin produced by Shigella dysenteraie (Head et al., 1988;Karmali et al.,

1985;Karmali et al., 1986). Shiga toxin genes are carried by all STEC and the toxin is

typically encoded by a lysogenic bacteriophage. Shiga toxin is cytotoxic to epithelial and
endothelial cells that carry the globotriaosyclceramide (Gb3) receptor (Karmali et al.,
1983a;Karmali et al., 1985). The first STEC strains were discovered in 1977 and isolated

in samples taken from patients with severe diarrhea (Konowalchuk et al., 1977). The
bacteria involved in those infections were found to produce a toxin that destroyed Vero

epithelial cells. Later work (O'Brien and LaVeck, 1983;0'Brien et al., 1982) purified the
verocytotoxin and it was shown to be identical to the toxin produced by Shigella
dysenteriae. Kidney damage suffered by patients with hemolytic uremic syndrome
(HUS)(Karmali et al., 1983b) is caused by the Shiga toxin produced by STEC.
Zoonotic STEC infections are acquired by ingesting contaminated water or food
but STEC are also transferable person-to-person (Melton-Celsa et al., 2012). Serotype

STEC 0157:H7 is the most commonly isolated STEC serotype that causes food and
water borne outbreaks in the United States. There are an estimated 63,153 cases of illness

caused by STEC 0157:H7 and 112,752 infections caused by non-0157 serotypes in the
US annually (Scallan et al., 2011). Based on genetic composition, STEC seropathotypes
are divided into two Major groups: (1) STEC 0157:H7 and its relatives comprise groups
1 and 2; and (2) STEC 09LH21 and related serotypes include STEC groups 3 and 4

(Melton-Celsa et al., 2012). Due to inadequate detection methods, the exact number of
cases of infection and death caused by non-0157:H7 strains are unknown (Henao et al.,
2010;Scallanetal.,2011).

Following ingestion of contaminated food or water, STEC groups 1 and 2 utilize
specialized adherence factors to move to the site of colonization, the large intestine, and
adhere tightly to colonic epithelial cells. Genetic markers that enable intimate adherence
of STEC 1 and 2 group members are encoded on a large pathogenicity island known as

the locus of enterocyte effacement (LEE) (McDaniel et al., 1995). The LEE is 42 kb and
codes for genes essential for host colonization. The LEE genes include the translocated

intimin receptor (tir), the major adhesion, intimin, coded for by the eae gene, the type III
secretion system and various other effector proteins (Elliott et al., 1998;Elliott et al.,
1999). Once contact is made with the host cell, the type III secretion system is assembled

and the Tir protein is translocated into the membrane of the host epithelial cell by way of
the type III secretion system (Kenny et al., 1997). Other host cell effectors secreted

through the type III system and made by STEC instruct host actin to form a pedestal-like
structure to which 0157:H7 attach. Adherence to the host epithelial cell layer leads to

effacement of the microvilli at the site of attachment and formation of a diagnostic scar
called the attach and efface lesion (A/E lesion) (Frankel and Phillips, 2008). Non0157:H7 STEC groups 3 and 4 isolates do not code for the LEE pathogenicity

island and do not form A/E lesions (Bugarel et al., 2010). However the STEC group 3

and 4 organisms do colonize the host and cause the same disease phenotype as do STEC
group 1 and 2 organisms (Scallan et al., 2011 ;Melton-Celsa et al., 2012).

STEC Infections and Associated Shiga Toxin

STEC infections sometimes present as bloody diarrhea or hemorrhagic colitis
(HC) and progress in 5-10% of cases to hemolytic uremic syndrome (HUS); a severe

sequelae that 10-15% of the time leads to kidney failure and death (Gould et al.,
2009a;Gould et al., 2009a;Gould et al., 2009b). Shiga toxin produced by STEC is the

major factor cause of kidney failure caused by toxin-exacerbated thrombocytopenia and
endothelial cell apoptotic cell death (Tesh, 2010).

Shiga toxin is released from the bacterial cell by an unknown mechanism and
binds to the host cell attaching to globotriaosyclceramide (Gb3) receptors present in the

plasma membrane of specific epithelial cell types (Abe et al., 2000;Okuda et al., 2006).
Following binding, Shiga toxin is phagocytosed brought into the endosome and

transported to the endoplasmic reticulum rather than being targeted for degradation (Raa
et al., 2009;Sandvig et al., 2010). The Al subunit of the toxin, the active domain, is

proteolytically cleaved and released into the cytoplasm of the eukaryotic cell where it
inactivates the large subunit of the host ribosome (Endo and Tsurugi, 1988b). The exact
mechanism of inactivation of the ribosome involves removal of amino acid A-4324

adenine base from the 28S rRNA by cleavage of the N-glycosidic bond (Endo et al.,
1988;Endo and Tsurugi, 1988a).

Shiga toxin is composed of two major subunits: (1) a 30 kDa A-subunit that
contains the active protein domain; and (2) the 35 kDa B-subunit, the binding domain
consisting of a pentamer of seven identical 7 kDA monomers ((Fraser et al., 2004). Two
major groups of Shiga toxin (Stx) exist which are immunologically distinct; they are

Shiga toxin types 1 and 2 (O'Brien et al., 1992). Variants of Stx2 that are found in STEC
include Stx2a, Stx2b, and Stx2c and Stx2dact. STEC 09LH21 and STEC O104:H21

carry the Stx2dact variant (Ito et al., 1990). The Shiga toxin Stx2dact variant is unique in
that when it is exposed to intestinal mucous the last two amino acids of the variant is

specifically cleaved by the elastase protein found in mucous. Following the elastase
cleavage Stx2dact toxicity is increased (Melton-Celsa et al., 2002;Kokai-Kun et al.,
2000;Melton-Celsa et al., 2002). The most clinically important Stx2 variants are Stx2c

and Stx2dact (Melton-Celsa et al., 2012) and are associated with poor clinical outcomes

The Type I and Type II Protein Secretion Pathways of STEC

The type I secretion apparatus - The type I secretion apparatus was first
described as the pathway for hemolysin toxin secretion in E. coli (Bauer and Welch,
1996). Hemolysin is a toxin carried by UPEC encoded on the hly operon. The hly operon
contains 4 genes: hlyC, hlyA, hlyB, and hlyD (Bauer and Welch, 1996). The hlyA gene
codes for the hemolysin toxin and the hlyC gene-product acylates and activates the HlyA

toxin (Bauer and Welch, 1996). Proteins required for HlyA secretion are coded for by
hlyB and hlyD. The HlyB and HlyD together interact with and recruit the type 1 secretion
pore, the TolC protein (Bauer and Welch, 1996;Koronakis et al., 2000;Stanley et al.,
1998). The type 1 pathway is also carried by STEC organisms and transports the
enterohemolysin toxin. The enterohemolysin toxin is discussed below in a different
section.

Type II Secretion Pathway - LEE-positive STEC such as 0157:H7 carry

genes for the type II secretion operon. Few proteins are known to depend on the type II
secretion pathway in STEC (Lathem et al., 2002). The type II secretion apparatus consists
of up to 13 genes that when expressed assemble into a multiprotein complex (Sandkvist,
2001b). Proteins that depend on the type II secretion apparatus are translocated from the
cytoplasm by the Sec secretion system. The nascent protein folds in the periplasm prior to
entrance into the type II secretion pathway (Sandkvist, 2001a) but the signal sequence

targeting proteins for secretion through the type II pathway is unknown (Johnson et al.,
2006). The complex is powered by the ATPase E protein which interacts with protein L
at the inner membrane interface. In Vibrio cholerae, membrane bound interaction of

proteins EpsE and EpsL are dependent on ATPase hydrolysis, therefore EpsE has dual
residence in the cytoplasmic and on the inner membrane bound to EpsL (Camberg and
Sandkvist, 2005;Patrick et al., 201 l;Robien et al., 2003). Protein C is periplasmic and it is

believed to be the gatekeeper for type II protein secretion pathway (Nunn, 1999). The
outer membrane pore is made up of 12 subunits of EpsD (Brok et al., 1999). It is thought
that in V cholerae EpsE, EpsL and EpsM regulate secretion by signaling through ATP
hydrolysis (Camberg et al., 2007).

The Major Adherence Factor for LEE-Negative STEC is Unknown

The type III secretion system and the major adherence factors Tir and intimin are
encoded by LEE-positive STEC 0157:H7 and non-0157:H7 STEC group 2 isolates
(Melton-Celsa et al., 2012). However, LEE-negative STEC 091:H21 and other group

3 and 4 isolates do not code for the LEE locus. Multiple adherence factors have been

identified that are carried by both LEE-positive and LEE-negative isolates. Yet intimin
and Tir are the only adherence proteins proven crucial for colonization of the human host.
In fact, there is no evidence available to date that explains the mechanism of adherence or
colonization for STEC 091:H21 and related isolates.

The Role of HNS in Regulation of Virulence Factors Carried by STEC

Virulence genes carried on the locus of enterocyte effacement (LEE) are tightly
regulated by a variety of regulator proteins. The major regulator of the LEE is the LEE
encoded regulator or Ler which activates expression of the LEE genes (Berdichevsky et
al., 2005); the Ler protein also regulates itself via an autorepressor mechanism
(Berdichevsky et al., 2005). The expression of the ler gene is regulated by the global
regulatory protein called the histone-like nucleoid structuring protein (HNS) (Bustamante
et al., 2001). The HNS protein represses LEE genes while the Ler protein counter-acts
HNS repression through activation of LEE gene expression (Bustamante et al., 2001).
Two other proteins found on the LEE locus have a role in LEE regulation. These proteins

are designated as the global regulator of LEE proteins called the GrlA [activator] and
GrlR [repressor]. The GrlA and GrlR proteins are encoded by the grlRA operon (Deng et
al., 2004;Lio and Syu, 2004).
LEE-negative STEC do not carry the LEE pathogenicity island or the Ler and

GrlAR proteins. In fact, the structural adherence genes required for host cell attachment
by LEE-negative isolates have not been identified. We propose that HNS must have a

role in regulation of key virulence factors because an HNS null mutant is defective in
binding human colonic epithelial cells (Scott et al., 2003). Furthermore, the HNS STEC

091:H21 mutant overexpresses its enterohemolysin toxin and is nonmotile (Rogers et al.,
2009;Scott et al., 2003). The facts taken together suggest that HNS simultaneously
regulates multiple virulence factors carried by STEC 091:H21.

The Large Virulence Plasmid Encodes the Enterohemolysin Operon of STEC

Both LEE-positive and LEE-negative STEC strains possess a large virulence
plasmid of approximately 100 kb pairs. The plasmid encodes a variety of virulence genes,

including a catalase peroxidase (Brunder et al., 1996), a serine protease (Brunder et al.,
1997), and the enterohemolysin operon (ehxCABD) (Schmidt et al., 1994). The
Enterohemolysin toxin (EhxA) is a member of the repeat in toxin (RTX) family of
cytolytic toxins which are widely distributed among many different Gram-negative
human and animal pathogens (Welch, 1991). These toxins have common features, such

as the capacity to disrupt and kill different types of cells through pore formation and lysis
(Stanley et al., 1998).

The most intensely studied member of the RTX toxin family is a-hemolysin
(HlyA) encoded by hlyA. Analysis of the deduced amino acid sequences of HlyA and
EhxA indicate that the toxins are related with 60% identity (Bauer and Welch, 1996). The

a-hemolysin protein is an important virulence factor of uropathogenic E. coli (Smith et
al., 2008). The enterohemolsyin toxin structural gene, ehxA, is a component of the
ehxCABD operon. The operon, when present, is always carried on the large virulence
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plasmid of clinical isolates of STEC (Schmidt et al., 1996). The gene products carried on
the ehx operon function exactly like those of the prototypic hly operon (Schmidt et al.,

1996). Specifically, the ehxB and ehxD genes code for the secretion system required for
transport of EhxA out of the cell (Bauer and Welch, 1996). Functional enterohemolysin

requires acylation of EhxA by the EhxC protein before it is secreted (Bauer and Welch,
1996).

The enterohemolysin operon in LEE-positive STEC species is regulated by Ler

(discussed above) in combination with GrlA and GrlR (Iyoda et al., 2011;Saitoh et al.,
2008). The enterohemolysin operon is not expressed under normal laboratory conditions;
with little or no toxin detected in the cell or in cellular extracts. Expression of the

ehxCABD operon is repressed by the HNS protein (Scott, et al, 2003) since a mutation in

the hns gene in LEE negative STEC serotype 091 :H21 incresed the produciton of
enterohemolysin which was then detectable under normal laboratory conditions (Scott et
al 2003). Therefore, although the mechanism of had not been discerned prior to our

investigations, we hypothesized that the HNS protein plays a role in regulation of
expression of the ehx operon even in the absence of the LEE encoded regulatory proteins.

What is Known about the Novel Lipoprotein, YghJ?

Shiga toxin-expressing isolates of E. coli that lack the LEE which contains the

type III secretion apparatus and Type III dependent host effector proteins, do not
produce and secrete the same proteinsas LEE-positive STEC. Analytical comparison of
the proteomes of LEE-positive STEC 0157:H7 with LEE-negative STEC 091 :H21
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revealed several novel proteins produced by LEE negative STEC 091 :H21 not produced
by STEC 0157:H7. Following two-dimensional gel electrophoresis and mass
spectrometry, one of these proteins was identified as YghJ.

A high-throughput pull-down assay using a histidine-tagged open reading frame
library constructed from published genome sequences of Escherichia coli strain K-12
used ORFs of 4339 genes cloned onto an expression vector as bait to evaluate proteinprotein interactions between histidine-tagged proteins and their interacting partners

(Arifuzzaman et al., 2006). This comprehensive shot-gun study indicated that YghJ
interacted with several proteins. All the proteins thought to interact with YghJ of localize
to the periplasm and many of these proteins bind to ATP. The proteins include: (1) the

FAD dependent malate dehydrogenase enzyme MQO; (2) the ATP binding subunit of the
D-allose transporter AlsA responsible for the uptake of the monosaccharide D-allose; (3)
the transketolase TktA, which possesses a thymine pyrophospate binding domain which
has an important role in the pentose phosphate and glycolytic pathways providing

precursors for nucleotide and vitamin biosynthesis; and (4), pitrilysin Ptr which is
responsible for cleaving carbohydrate substrates such as glucagon. Other uncharacterized
proteins include (1) YliA, a putative glutathione transporter with an ATP binding
cassette; (2) YaiN, a formaldehyde induced regulator protein; and (3) protein YmdF of
unknown function.

Interestingly, enteropathogenic E. coli seropathotypes also carry the yghJ gene
(see introduction, pg 12). Enteropathogenic E. coli (EPEC) seropathotypes carry the yghJ

gene and in EPEC YghJ may function in biofilm formation of EPEC(Baldi et al., 2012).
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In addition, a recent reverse vaccinology study identified in a mouse model of sepsis a

homolog of YghJ carried by an ExPEC isolate as a protective antigen (Model et al.,
2010).

The YghJ protein is likely homologous to the AcfD protein found in Vibrio
cholerae since the two proteins share 64% similarity. A possible role for YghJ in
bacterial-host interaction was described in Vibrio cholerae. Specifically, transposon
mutagenesis of V cholerae resulted in null mutants of AcfD that had an insertion within
the acJD gene, causing a disruption of function of AcfD, were unable to successfully
colonize the intestine of an infant mouse, the preferred animal model of cholera infection
(Peterson and Mekalanos, 1988).

Regulatory sequences upstream ofyghJ control transcription of the type II
secretion pathway in an Enterotoxigenic E. coli strain HI0407 (Yang et al., 2007). In this
ETEC strain, the yghJ gene is encoded on the chromosome upstream of the type II

Secretion operon (Yang et al., 2007). A transcriptional fusion revealed that jg/jJ is tightly
regulated by HNS in a temperature dependent manner (Yang et al., 2007). In addition,
reverse transcriptase PCR indicated that yghJ was contranscribed with the other genes in
the ETEC type II secretion operon resulting in a 14 gene transcriptional unit (Yang et al.,
2007).This group also suggests that YghJ is a substrate for the type II secretion. Evidence
presented herein does not support these findings.
The mission of the Human Microbiome Project is to describe the collections of

bacteria, fungi, and archaeae that inhabit the human body. Subsequently, a novel protein
called M60-like BT4244 produced by the human intestinal commensalist Bacteroides
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thetaiotaomicron (Collison et al., 2012;Nakjang et al., 2012) was identified and the

BT4244 protein was shown to degrade mucin in vitro (Nakjang et al., 2012). Further
analysis revealed an enzymatic domain near the carboxy-terminus on the protein
(Nakjang et al., 2012). The BT4244 protein is similar to a metalloprotease made by
Baculovirus called enhancin (Wang and Granados, 1997b). Baculovirus enhancin and the

BT4244 protein both possess a mucinase domain and a zinc-binding motif (Wang and
Granados, 1997b;Wang and Granados, 1997a;Nakjang et al., 2012). YghJ also contains
the mucinase domain as well as the zinc-binding motif. Therefore we speculate that YghJ
may have similar mucinase activity.

Mucin is routinely scavenged by bacteria as a carbon source (Collison et al.,
2012). Proteins that contain the M60-like domain are commonly detected in microbes
that inhabit a mucosa-associated environment which suggests a role for these proteins in
host colonization (Nakjang et al., 2012).

Rationale for These Studies

There are a number of major differences between virulence factors produced by
LEE-positive and LEE-negative STEC (Table 1). However, both types of STEC persist in
the host, colonize and cause identical infections. We have knowledge of many virulence
factors involved in LEE positive STEC infection but we do not know what is behind LEE
negative STEC pathogenesis. It is essential we begin to dissect the molecular
mechanisms important in host pathogenesis of LEE-negative STEC. As our food

production system becomes more industrialized and global, there are continual threats to
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our food supply from pathogens like STEC. The natural reservoir for STEC organisms

was thought restricted to bovine with infection occurring through consumption of
contaminated meat. More recently we find that STEC persist on vegetables that we grow

and consume, suggesting that we have not identified all sources of infection and novel
vectors of infection will continually arise. Discrimination between commensal E. coli and
non-0157:H7 isolates of STEC is difficult and inefficient which puts the population at
great risk. As a result, research focused on understanding mechanisms that underpin
pathogenicity of LEE-negative STEC must be intensified because more atypical STEC
serotypes are recognized as potent pathogens. Case in point is the recent LEE-negative
O104:H4 outbreak in Europe.

The work presented here is an attempt to identify differences in gene regulation of
the ehxCABD operon and to identify novel virulence factors that define mechanisms of
infection for LEE-negative STEC. By filling in the gap in knowledge we can leverage
this information in order to develop new treatments and detection methods. Here we
examine regulation of the enterohemolysin operon carried by LEE-negative STEC. We

found that the global silencer, HNS, directly regulates the ehxCABD operon of LEEnegative STEC by binding to its promoter region. Surprisingly we find that HNS also
binds to the same region of the ehx operon carried by LEE-positive STEC 0157:H7. We
characterized the product of the yghJ gene carried by LEE-negative STEC and found that

the YghJ protein provides a competitive growth advantage for LEE-negative STEC

091 :H21 when grown on carbon sources like L-malate. This growth advantage may be
important in carbon limited environments like the large intestine. This growth advantage
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may be important for survival on plants. We are intrigued by the recent discovery of the
mucinase domain in YghJ. We hypothesize that the capacity to degrade mucin into useful
carbohydrate metabolites such as glucosamine will likely play a strong role in host
colonization.

MATERIALS AND METHODS
Bacterial Strains and Growth Conditions

Table 2 describes pertinent facts about strains of bacteria and plasmids used in
this study. Bacterial strains were routinely grown to mid-logarithmic or stationary

phase in Luria broth (LB) at 37°C as specified. Antibiotics were added as needed and
applied at final concentrations for ampicillin (Ap) at 100 ug/ml, chloramphenicol (Cm)
at 30 jag/ml, and kanamycin (Km) at 50 ug/ml. The strain transformed with pT-hns/His
was grown in minimal media with 4% casamino acids then induced with 0.02%

arabinose for expression of hns. Isopropyl (3-D-l-thiogalactopyranoside (IPTG) was used
for plasmids with IPTG inducible promoters at concentrations required to induce
maximal gene expression.

Measurement of Extracellular Hemolytic Activity
The activity of enterohemolysin produced and secreted by each strain was

quantified by a tube assay modified from other procedures (Rennie et al., 1974;Welch
and Falkow, 1984;Williams, 1979). Bacterial strains were grown overnight in LB broth
at 37°C with aeration. The bacterial culture was diluted 1:50 into LB broth and grown
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with aeration until an optical density at 600 nm of 1.0 was reached. Concurrently, sheep
red blood cells (SRBC) were washed three times in sterile Dulbecco's PBS

supplemented with 10 mM CaCl2 and 0.1% BSA. A 2% SRBC solution of the washed
cells was prepared in Dulbecco's PBS supplemented with 10 mM CaCb and 0.1%

BSA. Once the STEC strains to be tested reached the desired optical density, the
supernatants were separated from the cells by centrifugation at 5,000 x g for 15
minutes. The supernatants were harvested and filtered to remove any remaining

bacterial cells or debris. Next, serial 2-fold dilutions of the supernatant filtrates were

made in Dulbecco's PBS supplemented with 10 mM CaCl2 and 0.1%> BSA. A 500 ul
sample of the diluted supernatant filtrates was added to an equal volume of washed 2%
SRBC solution in an eppendorf tube. The tubes were gently rocked to mix the
suspension for 4 hours at 37°C, with inversion of the tubes every 30 minutes. The tubes

were then spun in a microcentrifuge for 30 seconds at 13,000 x g. The resultant
supernatant was removed from each tube and the optical density at 540 nm measured.

The SRBC buffer was the control for background levels of spontaneous hemolysis.
Supernatants recovered from E. coli strains DH5a, DH10B, or plasmid-cured strain SI 1

served as negative controls. Maximum lysis was measured in samples that included 500
ul of water added to 500 ul of the 2% SRBC solution. Relative per cent lysis was
calculated as follows: 100 X (A540 of sample - A54.0 of background)/(As4o of total - A54o
of background).
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Detection of Hemolysis on Blood Agar Plates

Hemolysis activity by wild-type strains of E. coli that produce Shiga toxin can
not be detected on commercially prepared SRBC plates (Beutin et al., 1989). To
enhance the hemolytic activity of enterohemolysin on blood agar plates, SRBC were

prepared as follows. The SRBC used in the assay plates were washed three times in 10
mM PBS at pH 7.5 (Beutin et al., 1989). Tryptose blood agar was supplemented with
5% pre-washed SRBC and 10 mM CaCi2. Bacteria were applied to the blood agar plates

incubated overnight at 37°C in a 5% C02 atmosphere. The hemolytic phenotypes of the
bacterial strains were assessed following overnight incubation.

Preparation of Bacterial Lysates for Detection of Enterohemolysin by SDSpolyacrylamide Gel Electrophoresis (SDS-PAGE) and Immunoblot Analysis

Bacterial strains were grown overnight with aeration at 37°C in LB broth
supplemented with antibiotics as needed. The bacterial cultures were then diluted 1:50
into LB broth and grown with aeration to log phase. Bacterial cultures were equalized
by optical density readings at 600 nm. Next, half the culture of each strain was
removed and centrifuged at 5,000 x g at 4°C for 10 minutes. The supernatant was

removed and placed on ice. The bacterial pellets were resuspended in 10 ml of 0.1M
PBS. The resuspended pellets were sonicated to lyse the cells. The proteins were
precipitated from each of the sonically-disrupted samples by incubation with 10% final

concentration of trichloroacetic acid with rocking at 4°C overnight. Subsequently,

samples were centrifuged at 10,000 x g for 10 minutes to recover the precipitated
proteins. The supernatants were discarded and the pellets washed with cold acetone.

18

The pellets were dried and resuspended in SDS-PAGE loading buffer and frozen at 20°C.

Samples were heated to 100°C before loading onto 4-12% gradient SDS-PAGE

gels. Gels were run at 200 Volts for 50 minutes then stained with colloidal blue
(Invitrogen, Carlsbad, CA) or immunoblotted with Bordetella pertussis monoclonal

antibody, CyaA(9D4) specific for CyaA toxin CyaA(9D4) [Santa Cruz Biotechnology,
Inc., Santa Cruz, CA]. CyaA antibody binds to the nonapeptide repeat region of HlyA
and cross-reacts with EhxA (Bauer and Welch, 1996). Secondary antibody was goat

anti-mouse IgG (H + L) conjugated to horseradish peroxidase (Pierce, Rockford, IL).

Western blots were developed with a chemiluminescent substrate (Pierce, Rockford,
IL).

Cloning of ehxCABD from STEC 091:H21

Clinical isolates of STEC harbor a large plasmid (Levine et al., 1987;Schmidt et
al., 1996), the size of which varies among isolates (Brunder et al., 2006).
Representative plasmids carried by EHEC 0157:H" strain 3072/96 and by STEC
0113:H21 strain EH41 have been sequenced (Brunder et al., 2006) (Leyton et al.,
2003). The ehx operon was cloned from STEC 091 :H21 (B2F1) with sequence
information available for STEC Ol 13:H21 (EH41) (Leyton et al., 2003). The primer

pairs used to generate the ~7kb PCR fragment that contained the entire operon of ehx
are listed in Table 4. PCR amplification was done with PFU polymerase (Stratagene, La
Jolla, CA) and 100 ng of template genomic DNA isolated from B2F1. The
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concentration of each primer was 0.5 uM per 50 ul reaction. Amplification of ehx was
conducted under the following conditions: 1 minute at 95°C and 25 cycles of 30
seconds at 95°C, 50 seconds at 47°C, and 8 minutes at 72°C with a final extension for

10 minutes at 72°C. To create plasmid pCRehx, the resultant blunt-end PCR fragment
that contained ehxCABD was cloned into the Srfl restriction site of pPCR-Script Amp
SK (+) (Stratagene, La Jolla, CA). In addition to the open-reading frame of ehx, this
construct contained 126 bp of DNA sequence upstream of the start codon of ehx.

Cloning of Partial ehx Operon and Construction of pMCehxCAMacZ
Transcriptional Fusion Construct.

A clone of part of the ehx operon from strain STEC 091:H21 was generated to

contain 126 bp of DNA upstream of the start codon of ehxC, the entire coding region of
ehxC, and the first 695 bp of the coding region of ehxA. Primers were designed to
generate the partial ehx operon flanked by BamHI and EcoRI restriction enzyme sites
(Table 4). PCR with PFU polymerase (Stratagene) generates blunt-end PCR products,

so the partial ehx PCR product was blunt-end cloned into the EcoRVsite of pCR-Script
Amp SK (+) to create pCRehxCA'. The PCR reaction was done as follows: 1 minute at
95°C and 25 cycles of 30 seconds at 95°C, 50 seconds at 65°C, and 1.5 minutes at 72°C
and a final extension for 10 minutes at 72°C.

To create a transcriptional fusion of the putative regulatory sequences upstream

of the ehxCA' with the promoterless (3-galatosidase gene (lacZ), the ehx fragment was
removed from the pCR-Script Amp SK (+) by sequential digestion with EcoRI and
BamHI followed by ligation of the ehx fragment into the compatible EcoRI and BamHI
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sites of the pMC1403 vector that contains the promoterless lacZ (Casadaban et al.,

1980) to generate pMCehxCA '-lacZ. In the pMC1403 plasmid, the first eight codons of
the amino-terminal end of the lacZ gene that code for |3-galactosidase has been removed

and unique BamHI, EcoRI and Smal restriction sites inserted so that DNA fragments
with regulatory cis-elements and intact amino-terminal regions of any gene of interest,
when ligated into that site on the plasmid, will yield a hybrid protein that retains the

enzymatic P-galactosidase function. The pMC1403 vector has been used extensively to
identify cis-acting DNA elements required for transcriptional control (Casadaban et al.,
1980).

Cloning of hns from Strain B2F1

PCR was used to isolate the wild-type hns gene from B2F1. The primers used to

generate the hns gene are listed in Table 4. The primers were designed so that the PCR
product of the hns gene was flanked by EcoRI and BamHI restrictions sites. The hns
gene was blunt-end cloned into the Srfl site of the pCRScript Amp SK (+) cloning
vector. Then the hns gene was transferred from pCRScript Amp SK (+) by double
restriction enzyme digestion with EcoRIand BamHI, gel purified and cloned into the
EcoRI and BamHI cut low copy number cloning vector pMMB66EH to create
pMSlOOl.

Directional Cloning of hns into the pBAD202/DTOPO Expression Vector

Primer pairs were designed such that the forward primer contained a four base
overhang complementary (CACC) to the expression vector to permit directional insertion
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of hns into the pBAD expression vector, pBAD202/D-TOPO (Invitrogen, Carlsbad,
CA). Plasmid pMSlOOl that contained the hns coding sequence was used as DNA

template for the PCR reaction. The primer pairs are listed in Table 4. The forward
primer did not contain the start codon so that a translational fusion with the thioredoxin

protein could occur. The stop codon in the reverse primer was replaced with the alanine
codon so that the V5 epitope and the 6Histidine-tag (6His-tag) was fused in-frame to
hns; stop codons are present at the end of the 6His-tag sequence within the vector. PCR
amplification was done in a manner similar to that described above except that the

extension time at 72°C during amplification cycles was 0.5 minute. Amplification
yielded a 426 bp fragment that included the open-reading frame of the gene which
codes for HNS. The gene-product was designed to contain the HNS fusion protein with
the thioredoxin protein along with the V5 epitope at its amino-terminus and the 6Histag at its carboxy-end carried on the expression vector designated as pt-hns/his. This
construct yields an HNS-fusion protein product which is 31.4 kDa (HNS is 15.4 kDa;

thioredoxin is 13 kDa and the V5 plus 6His is 3 kDa).

Electrophoretic Mobility Shift Assay (EMSA).

Preparation ofthe HNSfusion protein- E. coli- LMG194 carries the
plasmid pt-hns/Ris that encodes the recombinant clone of HNS described above.

Cultures of LMG194 (pt-hns/Ris) were grown overnight with aeration in LB broth with
50 ug/ml of kanamycin. A 100-fold dilution of the overnight bacterial culture was made
into LB broth and grown at 37°C with shaking until an optical density at 600 nm of 0.2
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was reached. The culture was induced with 0.02% arabinose and allowed to grow for 4

additional hours, and bacteria were pelleted by centrifugation at 13,000 x G for 5
minutes. Cells were resuspended in 500 ul of lysis buffer that contained 50mM

potassium phosphate, 400 mM NaCl, lOOmM KC1, 10% glycerol, 0.5% Triton X-100,
10 mM imidazole. Lysis of the bacteria was done by freezing the resuspended cells in
an ethanol bath, then thawing the frozen organisms at 42°C. After lysis, the pellet was
separated from the supernatant by centrifugation at 13,000 x g for one minute. To
determine the amount of protein contained in the sample, two-fold serial dilutions were
made and compared to an albumin standard in a bicinchoninic acid (BCA) protein assay

(Pierce, Rockford, IL). The HNS fusion protein was extracted from the mixture with
Nickel-Chelated Agarose reagent by virtue of the 6His-tag (Pierce, Rockford, IL).
Preparation ofthepromoter region ofehx andprocedures ofthe
EMSA- Plasmid pCRehx was the source of the ehx putative promoter

region. Specifically, plasmid pCRehx was digested with EcoRIand Pmel, a process
which yield an 88 bp DNA fragment that contained the putative promoter region. The
88 bp fragment was gel purified and exacted with the Qiagen Gel Extraction Kit
(Qiagen, Valenica, CA). Next, 40 uM of DNA that contained 88 bp of DNA upstream
of the ehxC start codon was added to samples that contained decreasing concentrations

of his-tagged HNS at 0.2 uM, 0.1 uM, 0.05 uM, 0.025 uM, 0.0122 uM, and 0.006 uM
in binding buffer to a final volume of lOul. Binding buffer consisted of 750 mM KC1,
0.5 mM dithiothreitol, 0.5 mM EDTA, 50 mM Tris at pH 7.4. A negative control
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sample was included that contained only buffer added to the ehx DNA fragment. The
reaction mixture was incubated at 25°C or 37°C for 20 minutes and separated by 6%

polyacrylamide non-denaturing gel electrophoresis (Invitrogen, Carlsbad, CA). The
DNA within the gel was stained with Sybr-Green (Invitrogen, Carlsbad, CA) for 20
minutes and visualized with the Kodak Gel Logic 1500 Imaging System. Experiments

were repeated at least three times at both 25°C and 37°C. As a negative control, a 100
bp fragment of DNA from pCRScript Amp SK (+) was reacted with HNS under
identical conditions. In addition to the 88 bp fragment, the region of DNA 126 bp

upstream of the start codon of ehx cloned onto pMCehxCA '-lacZwas also tested by
EMSA for HNS binding.

Measurement of 0-galactosidase Activity

A microassay was used to quantitate the amount of p-galactosidase enzyme

produced in strains that carried the transcriptional fusion construct. The High
Sensitivity p-galactosidase Assay kit (Invitrogen) uses the galactosidase analog
chlorophenol red-P-D-galactopyranoside (CPRG) which is 10 times more sensitive than
the standard O-nitrophenyl- P-D-galactopyranoside (ONPG) substrate under similar
assay conditions. The CRPG substrate is extremely stable as it is resistant to proteolytic
enzymes typically present in bacterial lysates. The maximum absorbance of the
chromophore is 570 nm. Bacteria were grown in LB medium with or without antibiotics
at 37°C with aeration and harvested at mid-logarithmic growth. Lysates were prepared

and assayed at pH 7.5 and 37°C for 2.5 hours. Optical density readings were done at
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570 nm. All assays were performed in triplicate and repeated a minimum of three times
as per the manufacturer's instructions. The specific activity of P-galactosidase is

expressed as nmol of chlorophenol red formed x minute"1 x mg oftotal protein" which
is equal to the Units (U) of p-galactosidase activity per mg of total protein.

DNA Sequencing

The PCR fragment cloned into pCRehx was sequenced by Northwoods DNA,

Inc., Solway, MN. The PCR fragment was sequenced from both strands of DNA, and
each strand of DNA was sequenced twice with 100% agreement between each trial. The
PCR fragment cloned into pCB2YghJ was sequenced in the same manner.

Comparative Analysis of E. coli Grown on Specific Carbon Sources

Bacteria were grown overnight in M9 minimal media (20mM NH4CI, 25mM

KH2PO4, 40mM Na2HP04 at pH 7.4) supplemented with 0.2% of glucose at 37° C with
shaking except where otherwise indicated. The cultures were diluted 1:100 into M9

minimal media supplemented with 0.1%) of the indicated carbohydrate and grown for 12
or 24 hours at 37°C. All assays were performed in triplicate and repeated multiple times.
Over a 24 hour period, the relative growth of the cultures was determined by measuring
the optical density at 600 nm and plotting a standard growth curve of optical density over
time.

Cellular Fractionation to Determine Subcellular Location of YghJ

Spheroplastpreparation and sonication- Overnight bacterial cultures
grown at 37°C were harvested by centrifugation at 2,500 x g and spheroplasts prepared
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using a modified procedure based on a method by Osborn et al.(1992). The cell pellet

was resuspended in 200mM Tris buffer (pH 8.0) containing 0.2 mM dithithreitol (DTT).
An equal volume of 1 M sucrose containing 10 mg/ml lysozyme was added to the cell
solution and the mixture incubated on ice for five minutes. Then an equal volume of ice
cold distilled water was added to the solution. After incubation on ice for 10 minutes, the

cells were lysed by sonication and unbroken cells were removed by centrifugation at
2,400 x g.

Triton X-100 subcellularfractionation - Inner membrane proteins were extracted
with triton X-100. Triton X-100 is a nonionic detergent that solubilizes inner membrane

proteins leaving outer membrane proteins intact (Filip et al. 1973). The spheroplasts were

prepared as described above. The pellet was recovered and washedtwice in 50 mM Tris
containing 0.2 mM DTT. After incubation on ice for 30 minutes, the sample was split
into two separate aliquots that included (1) the total membrane extract and (2)soluble

proteins from the cytoplasm and periplasm recovered by centrifugation at 160,000 x g for
4 hours. After centrifugation, the triton X-100 inner membrane fraction was extracted
from the membrane pellet using 2% triton X-100 in 50 mM Tris (pH 8.0) containing

MgCl and 0.2 mM DTT. The membrane fraction containing only the outer membrane
proteins was separated by centrifugation at 160,000 x g for one hour This resulted in the
triton X-100 soluble inner membrane proteins and the urea soluble outer membrane

proteins. The pellet, which contains outer membrane proteins, was solubilized prior to
PAGE analysis in 50 mM Tris-HCl (pH 7.4) containing 5 M urea. All subcellular
fractions were analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis
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(SDS-PAGE). The cytoplasmic and non-attached periplasmicproteins, triton x-100
soluble inner membrane proteins, and the urea extracted outer membrane fractions are

shownas: (cyto), the combined cytoplasmic and periplasmic solubleproteins; IM; and
OM respectively.

Globomycin Inhibition of Signal Sequence Cleavage of YghJ

The antibiotic globomycin specifically inhibits the signal peptidase II enzyme

(LspA), which cleaves the nascent prolipoprotein at its diacylglycerol modified cysteine
residue (Tokunaga et al 1982). The histidine-tagged recombinant YghJ protein expressed
from the inducible pET21a expression vector was used in this analysis. Strains were

grown to an optical density at 600 nm to 0.600 prior to addition of globomycin.
Globomycin was added to the strains above at the following concentrations: 200 mM,
100 mM, and 50 mM. Samples were taken every 2 hours for 6 hours. After treatment

with globomycin, cells were harvested by centrifugation and proteins solubilized in 50
mM Tris (pH 7.4) containing 0.1% SDS. The protein concentration of each samplewas
determined, samples equalized and then analyzed by SDS-PAGE.

Cloning the yghJ Gene along with Upstream and Downstream Intervening
DNA Sequences: Construction of Plasmid pCRB2yghJ.2 that Contains the
Full Transcriptional Unit ofygM from STEC 091:H21 Strain B2F1
Plasmid pCRB2yghJ contains full-length yghJ cloned by PCR from STEC
091 :H21. In STEC 091 :H21, XheyghJ gene is flanked by intervening DNA sequences;

specifically 583 bp of DNA downstream ofglcA and 276 bp DNA upstream of pppA. In
the commensal E. coli K-12 substrain MG1655, the location ofyghJ is the same but the
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amount of intervening DNA is different. See Figure 1 below which compares the location
ofyghJ in the two strains. Therefore we used primers that code for sequences at the end

ofglcA and fall within pppA. Gene releaser (Bioventures, Murfreesboro, TN) was used
to extract genomic DNA from both STEC 091 :H21 and MG1655 used in the PCR
reaction.

Genome sequence data was acquired from accession #U00069 which includes the

whole genome sequence of Escherichia coli K12- substrain MG1655 (Figure 1). The
yghi gene is located at 3,112,572-3,117,134 on the MG1655 chromosome. Comparison
of the amino acid sequence of YghJ carried by MG1655 and STEC 091 :H21 indicates
that the proteins are 99% identical. Further studies to characterize the function of the

YghJ protein was done in a E. coli K-12 background to avoid inherent problems in
handling the STEC 091 :H21 pathogen.
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Figure 1. Schematic representation of the position of yghJ on the chromosome. The
intervening Sequence for STEC 091 :H21 is shown in white and MG1655 is shown in
gold.
PCR reactions were done with Phusion a high-fidelity DNA polymerase
(Finnzymes-New England Biolabs, Ipswich, MA). PCR with Phusion results in a bluntended DNA product. PCR with primers CTG-IOF and CTG-20R generated the full-length
yghJ transcriptional unit flanked by Xba\ and Kpnl enzymes. The PCR fragment generate

from STEC 091 :H21contained 5439 bp of DNA. This fragment of DNA contains the
yghJas well as non-coding intervening sequences downstream ofglcA and upstream of
pppA genes. The PCR reaction was done by the two-step method as follows: 30s at 98°C
and 25 cycles of 30 s at 98°C, 2 minutes at 72 °C with a final extension for 10 minutes at

72 °C. The PCR fragment was blunt-end cloned into the EcoRV site of pPCRScript Amp
SK (+) to create pCRB2yghJ.

Figure 2 is a picture of the PCR product and results of screening of putative
clones that carry the plasmid of interest. The DNA fragments recovered after PCR from
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B2F1 and MG1655 were of the expected size. The yghJ PCR product from DH5a is
much smaller but correlates with the reported size of the yghJ gene-fragment carried by
this strain of E. coli.

Figure 2. PCR product and results of screening of putative pCB2YghJ clones. Panel A is
PCR product from STEC 091 :H21 strain B2F1, Panel B is a comparison PCR product
using the same primer set for genomic DNA of MG1655, Panel C is a restricition analysis
of pCB2YghJ clones cut with Kpnl and Xbal.
The ligation mixture was transformed into DH5a and selected on LB agar

containing ampicillin. Clones surviving selection were tested for the presence of the
plasmid using the Qiagen Plasmid Extraction Kit (Qiagen,Valenica, CA). Isolated
plasmids were cut with Xbal and Kpnl to determine if an insert was present. Plasmid

pCB2YghJ, shown in panel C above contains the insert. This plasmid was sequenced by
overlapping primer design. This construct contains the complete yghJ transcriptional unit
as well as DNA sequences that flank the yghJ gene.
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Cloning of yghJ from E. coli MG1655 and Generation of the HistidineTagged Recombinant YghJ

Cloning the open-reading-frame (ORF) ofyghJ- PCR reaction was

done using genomic DNA prepared from E. coli MG1655. Primer pairs YghJ-5FA and

YghJ-6RA were used to createa modified blunt-end DNAproduct containing the proteincodingDNA sequence of ygh] (ORF-yghJ) flanked by BamHI and EcoRI restriction
sites. The PCR reaction was done by the two-step method as follows: 30s at 98°C and 25

cycles of 30 s at 98°C, 2 minutes at 72 °C with a final extension for 10 minutes at 72 °C.

myghJ

30001

I pCRScript

2000]
1500
1000

500

Figure 3. Restriction analysis of pCMGORFyghJ clones.

The modifiedyghJ sequence obtained contained the translational start codon but

without a stop codon. The modifiedyghJ ORF sequence was cloned by blunt-end ligation
into the Srfl restriction site of pPCRScript Amp SK (+) to create pCMGyghJ. The

pPCRScript Amp SK (+) plasmid provides the stop codon for the clonedyghJ fragment.
Clones were screened by restriction analysis with BamHI and EcoRI enzymes.

Clones 3, 7 and 9 all contained yghJ DNA of the correct size, shown in Figure 3. Clone
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pCRMGyghJ.7 was used for cloning into pET21a to prepare his-tagged YghJ
recombinant protein.

Preparation ofrecombinant his-tagged YghJprotein-VXasmiti. pCRMGyghJ.7 was
cut sequentially. First the plasmid was cut with EcoRI which liberated a 4560 bp DNA

fragment that containedyghJ. This fragment was gel extracted then cut with BamHI. The
resultingyghJ DNA fragment flanked by BamHI and EcoRI was cloned inframe into
BamHI and EcoRI restricted sites of the T7 expression vector pET21a; creating plasmid

pETORFMGyghJ. Plasmids were screened by PCR analysis using forward primer YghJ5FA and reverse primer YghJ-6RA. Clones 1, 2, 3, and 5 contained theyghJORY. These
cloneswere selected and frozen. The ORF ofyghJ was moved from pPCRScript Amp SK
(+)into the pET2la vector.

Directional Cloning of yghJ onto pBAD TOPO Expression Vector to Create a
YghJ Fusion Protein Containing a N-terminal Thioredoxin and C-terminal
Polyhistidine Tag

This construct was generated in an attempt to produce a thioredoxin-YghJ fusion

protein that would remain cytoplasmic. The hope was that this construct would be stable
enough because of the thioredoxin tag and could be purified by metal chelating resins.
The construct was designed so that the thioredoxin protein could be cleaved after

purification releasing an intact YghJ protein without the thioredoxin fusion partner. This
was done because the YghJ-his-tagged recombinant proteins cloned from both STEC

091 :H21 and MG1655 and expressed from the pET2 la vector did not stick to any of the
metal chelating resins we used for purification. NOTE: Sequencing across the joint
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between the yghJ gene and the histidine codons indicated that the yghJ gene is inframe.
However, Western blot analysis of the recombinant Ygh-his-tag fusion protein indicated
that the histidine tag, if present, could not be detected by this method.
To create a thioredoxin-YghJ fusion protein, the ORF ofyghJ was acquired by
PCR from E. coli MG1655. The blunt-end DNA fragment was the expected size at 4560

bp. The DNA was cloned inframe with the thioredoxin gene by inclusion of four
nucleotides, CACC, in the forward primer sequence. Directional cloning was obtained by
CACC base pairing of the PCR product with the GTCC sequence in the pBAD202/DTOPO vector. Blunt-end PCR reaction was done with PFU ultra II Fusion HS DNA

polymerase (Agilent Technologies, Santa Clara, CA). The reaction procedure included:
Denaturing step at 95°C for 5 minutes, followed by 25 cycles of 95°C for 1 minute, then
30 seconds at 55°C, extension for 2.25 minutes at 72°C; ending with 10 minutes at 72°C.

Five clones were selected, analyzed and frozen prior to protein expression studies.
The Hindlll restriction enzyme occurs once in the expression vector and does not occur
within the yghJ gene, so restriction with Hindlll should linearize the plasmid. Hindlll
restriction resulted in one band of the expected size of 9010 bp.

Induction of the Topo-YghJ-6X His fusion protein from the pBAD202/DTOPO plasmid

Cultures of E. coli LMG194 (PbadMGYghJ) were grown overnight with aeration

in LB broth with 50 ug/ml of kanamycin. A 100-fold dilution of the overnight bacterial
culture was made into LB broth and grown at 37°C with shaking until an OD600 nm of
0.2 was reached. The culture was induced with varying concentrations of arabinose and
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allowed to grow for 8 additional hours. Bacteria were pelleted by centrifugation at
6,000 x G for 5 minutes. Samples were lysed by resuspension in SDS loading buffer.
Proteins were separated by SDS-PAGE in a 4-12% Bis-Tris gel. Proteins were
visualized using Coomassiee Brilliant Blue R-250.

Induction and Purification of YghJ-6X His Recombinant Protein Using
Clonetech HisTalon Gravity Columns

Bacterial cultures were grown overnight in LB media containing 100 ug/ml

ampicillin then diluted 1:100 into LB media with antibiotic. Diluted cultures were grown
to an OD600 nm of 0.600 and cultures were induced for expression ofyghJ by addition

of 100 mM Isopropyl P-D-1-thiogalactopyranoside (IPTG). Following addition of IPTG,
cultures were grown for 6 hours to produce YghJ. Cells were harvested by centrifugation
for 15 minutes at 2,400 x g. Bacteria were lysed using the Talon xTractor Buffer

(Clonetech, CA) containing 1 mg/ml lysozyme and 1 ug/ml DNase I and EDTA free
protease inhibitor cocktail (Sigma-Aldrich) according to manufacturer's specifications.
The HisTalon gravity metal affinity column (Clontech, CA) was used for protein

purification. Briefly, the sample was loaded onto an equilibrated column and washed with
3x column volumes of wash buffer (50 mM sodium phosphate, 300 mM NaCL) before

eluting with buffer containing 400 mM imidazole at pH 7.4 A second attempt was made
at purification using the same conditions with buffers containing 0.1% Triton X-100 .
Protein levels were quantified and equalized before SDS-PAGE analysis.
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Induction and Purification of YghJ-6X His using Pierce B-PER 6XHis
Fusion Protein Purification Kit

Bacterial cultures were grown overnight in LB media containing as described above.
Diluted cultures were grown to an OD600 nm of 0.600 and cultures were induced for
expression ofyghJ by addition of 100 mM IPTG. Following addition of IPTG, cultures

were grown for 6 hours for YghJ production. Cells were harvested by centrifugation for
15 minutes at 2,400 x g. Cultures were lysed using the Pierce Bacteriral Protein Extract

Reagent containing EDTA free protease inhibitor cocktail (Sigma -Aldrich, CA)
overnight at 4° C. The lysate was incubated with nickel-chelate agarose for one hour. The
flowthrough was removed by centrifugation and the nickel-chelate agarose was washed
three times with the wash buffer supplied with the kit. The protein was eluted as per
manufacturer's instructions using the included elution buffer. Protein levels were

quantified and equalized before SDS-PAGE analysis. In some cases, p-mercaptoethanol
was included as an antioxidant.

Purification Attempt of YghJ-6X His using Invitrogen Dynabeads His-Tag
Isolation Beads

Bacterial cultures were grown overnight in LB media as described above.
Expression ofyghJ induced by addition of 100 mM IPTG as described above and cultures
were grown for 6 hours for YghJ production. Cells were harvested by centrifugation for
15 minutes at 2,400 x g. Bacteria were lysed using the Talon xTractor Buffer (Clonetech,
CA) containing 1 mg/ml lysozyme and 1 ug/ml DNase I and EDTA free protease
inhibitor cocktail (Sigma- Aldrich) according to manufacturer's specifications. Membrane
debris was removed by centrifugation at 20,000 rpm for 30 minutes. The cleared lysate
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was incubated with 2 mg of dynabeads with rocking at 4° C for one hour. The dynabeads
were immobilized using a magnet and the lysate was removed. Beads were then washed
three times in a 50 mM sodium phosphate buffer. Proteins were eluted using a 50 mM
sodium phosphate buffer containing 200 mM imidazole. The purification was analyzed
by SDS-PAGE gel electrophoresis.

Western Blotting of YghJ-6X His

A Western blot was done to detect the recombinant protein. Cultures of

BL21(DE3) containing both plasmids pETORFB2YghJ-His or pETORFMGYghJ were
induced. Lysates prepared and proteins separated on an 8% polyacrylamide gel. Proteins

were electrophoretically transferred to a nitrocellulose membrane post SDS-PAGE and
blocked overnight in 5% milk. The membrane was incubated with the primary antibodies
separately, either India His-HRP (Pierce, Rockford, IL) at 400 ug/ml in PBS and Covance
anti-His antibody (Covance, Princeton, NJ.) at 100 ug/ml in PBS. The Covance anti-His

was then treated with a goat anti-mouse HRP conjugated antibody (Pierce, Rockford, IL).
Western blots were developed with a chemiluminescent substrate (Pierce, Rockford, IL)
and the results compared with the Kodak Gel-Logic 1500 Imaging System.

In Gel Assay to Detect Phosphatase Activity of YghJ
The fluorogenic substrate 4-methylumbelliferyl phosphate (MUP) can be used to
visualize phosphatase activity from proteins present in a polyacrylamide gel.
Dephosphorylation of the substrate causes a fluorescent band to form where phosphatase
enzyme localizes following separation in the PAGE gel. Total lysate or extracted
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membrane protein from E. coli K12 containing yghJ expressed from a high copy number
plasmid was separated into a denaturing 4-12% Bis-Tris gel. Post-run, the gel was
washed twice with 20% isopropanol in 50 mM Tris-HCl (pH 7.5) for one hour per wash.
A further step was done in denaturation buffer containing 50 mM Tris-HCl (pH 7.5), 5
mM P mercaptoethanol, and 8 M urea for one hour at room temperature. The proteins
were renatured in a buffer containing 50 mM Tris-HCl, 0.02% Tween, 20 mM P

mercaptoethanol and 1 mM MgCb for 16-20 hours. After renaturation, the gel was
incubated with the substrate containing 50 mM Tris-HCl (pH 8.0) 0.1 mM EGTA, 0.01%
Tween, 2 mM DTT, 20 mM MnCl2, and 0.5 mM MUP. The gel was for 15 minutes
before observing fluorescent bands.
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Table 1: Virulence Factors Produced by LEE-Positive STEC as
compared to Virulence Factors Produced by LEE negative STEC
Protein

LEE ne<gative

LEE positive
0157:H7

09LH21

O104:H4

HNS

+

+

+

GrlA

+

-

-

GrlR

+

-

-

Ler

+

-

-

Enterohemolysin
Shiga toxin

+

+

+

+

+

+

intimin

+

-

-

Tir

+

-

-

Type III secretion
Type II secretion

+

-

+

-

+

-

+

Plasmid encoded

+
-

toxin (Pet)
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Table 2. List of strains used in this study

E. coli Strain

Relevant Features

DH10B

Cloning strain, non-hemolytic

DH5a

K-12 cloning strain, non-hemolytic

WAF100

Reference

(Grant et al., 1990)
(Silhavy and
Beckwith, 1983)
(Welch and
Falkow, 1984)

(pSF4000)

Strain HB101 with a-hlyCABD

DH10B(pB2Fl)

DHlOB(pCR^x)

Plasmid pB2Fl [encodes ehx]
ehx operon from B2F1 cloned into
pCRScript

This study

TOP 10

araDl 39A(ara-leu) 769 7

Invitrogen

LMG194

deleted for araBADC

Invitrogen
(Karmali et al.,
1986)

STEC091:H21
str. B2F1
STEC09LH21

eae negative, ehx , hns
plasmid-cured derivative of B2F1,

This study

(Scott et al., 2003)

str. SI 1

ehx', hns

STEC09LH21
str. 34.7

hns::mini-Tn5phoACmr, ehx",
hyper-hemolytic

THK62

hns null mutant

BL21(DE3)

T7 promoter

K-12MG1655

Wild type YghJ

(Scott et al., 2003)
(Donato et al.,
1997)
(Studier and
Moffatt, 1986)

BW25113

Wild type YghJ

(Blattner, 1997)
(Datsenko and
Wanner, 2006)

STEC0157:H7

LEE positive, YghJ negative

(Karmali 1985)

B strain
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Table 3. List of plasmids used in this study
Plasmid

Relevant Features

Reference

pBAD202/DTOPO

Expression cloning vector

Invitrogen

pCRScript Amp
SK(+)

Cloning vector, bid

pSF4000

pACYC184 vector with a-hlyCABD

Stratagene
(Welch and Falkow,
1984)

pMMB66EH

Low copy IPTG inducible vector

(Furste et al., 1986)

hns from STEC 091:H21 str. B2F1

pMSlOOl
pCRehx
pT-hns/His
pMC1403

pCRehxCA'

pMCehxCA'-lacZ
pET21a

pCBlyghJ

pCORFBlyghJ
pCORFMGyghJ
pETBlyghJ
pETORFBlyghJ

pETORFMG^J
pBADMGyghJ

carried on pMMB66EH
ehx carried on pCRScript Amp SK(+)
hns fused with his-tag and thioredoxin
on pBAD202/D-TOPO
promoterless lacZ vector for
transcriptional fusions
upstream regulatory sequences, ehxC
and part of ehxA on pCRScript Amp
SK(+)
promoter region, complete ehxC gene
partial ehxA fused with lacZ gene on
pMC1403
IPTG inducible vector

yghJ from B2F1 including upstream and
downstream sequence on pCRScript
Amp SK(+)
open reading frame ofyghJirom B2F1
on pCRScript Amp SK(+)
open reading frame ofyghJ from
MG1655 on pCRScript Amp SK(+)
yghJ from B2F1 including upstream and
downstream sequence on pET21a
open reading frame ofyghJ from B2F1
onpET21a
open reading frame ofyghJ from
MG1655onpET21a
open reading frame ofyghJ from
MG1655 on pBAD202/D-Topo
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(Scott, 2003)

This study
This study
(Casadaban et al.,
1980)
This study

This study
Novagen

This study
This study
This study
This study
This study
This study

This study

Table 4. List of primers used in this study
Gene

Primer Sequence
EhxF:5'-TACGTATAGATGCTTCTTGCTTAAAAGGATATAAT-3'

ehx operon
EhxR:5'-CCTAGGTATACTAACGTTCACGTAAACT-3'
EhxF:5'-GAATTCTTGGGAGGGATTCTCCTTGCGGTAGC-3'

partial ehxCA
EhxR:5'-GGATCCCCGGAGACAACATCCAGCCCAT-3'
HNSF:5'-AGAATTCATGAGCGAAGCACTTAAAATTCT-3'
hns
HNSR:5'-AGGATCCTTATTGCTTGATCAGGAAATC-3'
HNS 1F: 5'-ACCAGCGAAGCACTTAAAATTCTGAACAACATCCGTA-3'

hns-rris
HNS2R:5'-GAAATTGCTTGATCAGGAAATCGTCGAGGGATTTACC-3'
CTG-IOF 5' TCTAGACATGGTGGGCCGAGAATCTGAAC-3'

pCB2YghJ
CTG-20R5'GGTACCACATTTCACCGTGAAACTCC-3'

ORFMGYghJ

YGHJ-5FA5'-CGGGATCCTCACTTGCGTTATTAATGAATAAGAAATTT-3'

&

ORFB2YghJ
YghJ-Topo

YGHJ-6RA5TAGAATTCAAACTCGGCAGACATCTTATGCTC-3'

YghJ-BAD 1F 5'-CACCATGAATAAGAAATTTAAATATAAGAAATCGCTTT-3'

RESULTS

Proteomic Analysis and Comparison of Shiga Toxin-Producing Escherichia
coli (STEC) 091:H21 and STEC 0157:H7 Isolates

Comparative Two-Dimensional Gel Analysis ofExtracytoplasmic Proteins
from LEE-negative versus LEE-positive STECExtracellular proteins were recovered from two STEC isolates: (1) STEC 091:H21 a
LEE-negative strain and (2) STEC 0157:H7 the LEE-positive isolate. The protein
profiles were examined by SDS-PAGE gel. Then separated by molecular weight in a onedimensional gel and visualized by silver staining (Figure 4). After separation, a high
molecular weight protein of approximately 160 kDa was visible in the STEC 091 :H21
isolates but was not present in the sample from STEC 0157:H7. In addition HNS did not
appear to inhibit expression of the 160 kDa protein because it is present in the STEC
091:H21 HNS knockout mutant designated as 34.7. Furthermore, the novel gene-product

is not carried on the large virulence plasmid but is coded for on the chromosome since the
plasmid-cured variant of STEC 091 :H21 called SI 1 still produced the protein. However,
there appears to be lower levels of the protein in SI 1 which suggests but does not prove

that gene-products encoded on the large virulence plasmid may play a role in its
expression. See Figure 4 which is representative of the data discussed above.
To ensure that proteins detected were distinct, two-dimensional gel

electrophoresis was used. A representative gel is shown in Figure 5. The protein profiles
of STEC 09LH21 as compared to 0157:H7 showed several differences. Arrow one
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indicate the 160 kDa protein of interest. Other differences in the protein profile are
indicated by numbered arrows.

YgnJ

q o 3 «j W

Flic

17

Figure 4. Two-Dimensional Gel Analysis of the Proteomes of LEE-negative STEC
09LH21 and LEE positive STEC 0157:H7. YghJ is indicated by an arrow. The flagellin
protein FliC, expressed at high levels in wildtype 091 :H21 and not expressed in the HNS
mutant indicated by an arrow.
LEE-negative STEC 091:H21

LEE-positive STEC 0157:H7
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Figure 5. Two-Dimensional Gel Analysis of the Proteomes of LEE-negative STEC
091 :H21 and LEE positive STEC 0157:H7. Red numbers indicate proteins reduced or
are not present in STEC 0157:H7 and Blue numbers indicate proteins reduced or not
present in STEC 09LH21.

In Figure 6 STEC 09LH21 two-dimensional gels are shown. In panel A a portion of a
coomassie stained gel is shown; an arrow marks the location of the protein of interest
which was cut out and sent for mass spectrometry to identify the protein (Chad Trumble
Master's Thesis 2009). Panel B is the silver stained 2-D gel used to confirm the presence
and location of the 160 kDa protein.

Coomassie

Figure 6. Two-dimensional gel analysis of STEC 091:H21. YghJ and the flagellar
protein FliC are indicated with arrows. Bands of interest were excised from the

coomassie stained gel and sent for LC/MS/MSE to identify the proteins. The silver stain
was used for protein visualization.
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Genetic Analysis of the 160 kDa Protein Identified as YghJ: a Novel
Extracytoplasmic Protein Produced by STEC 091:H21

Location oftheyghJ gene on the chromosome ofSTEC 091.H21 and E.
coli Kl2

substrain MG1655-

LC/MS/MSE analysis revealed the 160 kDa protein to be an uncharacterized protein

called YghJ (Chad Trumble Master's Thesis, 2009). Colony blot analysis of the wild-type
091 :H21 and its plasmid cured variant SI 1 confirmed the presence of yghJ in both
strains, indicating thaiyghJ is present on the chromosome (Chad Trumble Master's

Thesis, 2009). The genome sequence is unpublished for STEC 091 :H21, so the
commensal E. coli K12 substrain MG1655 (Blattner et al., 1997) was used for further

genetic analysis. Accession# U00096 describes the genome sequence of MG1655. The
yghJ gene is located on the chromosome 197 bp upstream of the pre-pillin peptidase A
(pppA) gene and 517 bp downstream of the glycolate permease A (glcA) gene. See
Figure 1 on page 7, a schematic that shows the location of the yghJ gene on the
chromosomes of MG1655 and STEC 09LH21.

We amplified the yghJ gene from STEC 09LH21 and MG1655 as described
above using primers which were complementary to the 3'-end of the glcA gene and the
5'-end at the beginning of thepppA gene, indicating thatyghJ is located between the glcA
and pppA in both MG1655 and STEC 09LH21. However, the amount of intervening

DNA nucleotides varies between the two E. coli strains. Specifically STEC 091 :H21
contains 79 more DNA base pairs than does MG1655 in the intergenic space between
pppA and yghJ, and 66 more base pairs between the glcA gene and the yghJ gene.
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However, the amino acid sequence of the protein itself shares a 99% identity between the
two isolates. Therefore, to prevent any risks associated with the use of pathogens,
MG1655 was used throughout this study.
Phylogenetic analysis of YghJSimilar YghJ proteins found in other Gram-negative bacterial species

The Basic Local Alignment Search Tool (BLAST) was used to search for proteins
similar to YghJ in other bacterial species with sequence data from the E. coli K12 strain

MG1655 (Accession YP_026189). Results of this comparison are shown in Figure 7.
YghJ is related to the AcfD protein of Vibrio cholerae, which is known to play a role in
colonization of the large intestine in the infant mouse model (Peterson and Mekalanos,
1988). The AcfD proteins from V cholerae appears to cluster when using the nearest
neighbor joining method, indicating a close relationship between these proteins; the

proteins share a 67% identity with the YghJ protein from E. coli MG1655. AcfD proteins
from other Vibrio species which share a slightly lower identity to YghJ are also found in
other Vibrio species including V. vulnificus, a marine bacteria, V. parahemolyticus and V.
mimicus, pathogenic isolates which cause gastroenteritis but do not produce cholera toxin
(Chowdhury et al., 1987). V. harveyi and Vfischeri, two bioluminescent bacteria often
associated with marine animals also carry the acfD. Other bacterial isolates encoding

yghJ-like genes include Grimontia hollisae, a pathogen formerly classified as Vibrio
hollisae that causes gastroenteritis, Photobacterium damselae, known to cause infection
and illness and death in fish, and two Shewanella isolates, S. halifaxensis and S.

pealeana, both marine bacteria carry homologues of YghJ. Interestingly, all of the genera
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that contain the yghJ gene have two distinct lifestyles, surviving in such disparate
environments as a salty marine environment and the intestines of warm-blooded
mammals.

YghJ is distributed throughout both commensal and pathogenic E. coli

strains Figure 8 shows the Phylogenetic relationships of YghJ protein sequences from
Escherichia organisms based on BLAST analysis. Numbers shown at nodes represent

values based on 100 bootstrap replicates. Bootstrap replicates indicate the probability of
the same species being placed into the same node in a set of 100 predicted phylogenetic
trees. YghJ is present in several Escherichia species, including E. albertii, a strain
associated with diarrheal disease (Huys et al., 2003) as well as E.fergusonii, a species
which is often associated with wound infection and bacteremia. YghJ is also present in

the pathogenic Shigella sp. D9. Among the E. coli species, there appear to be three
distinct subtree groupings. However, no immediate relationship between species in the
three groups can be identified.

YghJ appears in pathogenic strains including uropathogenic E. coli (UPEC),
enterotoxigenic E. coli (ETEC), enteropathogenic E. coli (EPEC), enteroinvasive E. coli
(EIEC), enteroaggregative E. coli (EAEC) and extraintestinal E. coli (ExPEC) isolates.
YghJ proteins from seropathogenic strains do not appear to bear any significant
differences in the proteins produced relative to YghJ proteins produced in nonpathogenic
or commensal E. coli. Thus, there are no identifiable phylogenetic pathogenic groupings

detectable. All bootstrap values are above 98, indicating a high relationship between
sequenced YghJ proteins in Escherichia species and high similarity of proteins ranging
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from 87% identity in E.fergusonii to between 98% to 100% identity among most E. coli
isolates.
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Figure 7. Phylogenetic relationships of YghJ protein sequences produced by other Gram negative species based on
neighbor joining analysis.
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Structure/Function Analysis of the Novel Protein, YghJ.
Structural and Functional Domains ofYghJ-Yrotein alignment analysis

using The Basic Local Alignment Search Tool (BLAST) and the Simple Modular
Architecture Research Tool (SMART) revealed that YghJ contains a lipoprotein signal
sequence which spans residues 1-26. The amino acid sequence is
[MNKKFKYKKSLLAAILSATLLAGCDG] Sutcliffe and Russell (1995). This sequence
contains the lipoprotein processing consensus motif, or lipobox, LAG/C D G . The YghJ
protein also contains a DUF4092 (Pfam 13322) domain of unknown function from amino
acid 416 to 585 (Figure 9). This domain also appears in other proteobacteria such as V.

cholerae and V parahemolyticus AcfD proteins. Proteins with this domain may be
involved with metabolic pathways including nucleotide metabolism.

LAGCD

1520

Signal Peptide
Lipidation site
(1-26)

DUF4092
(416-585)

M60-Like domain
(1081-1381)

Figure 9. Schematic diagram of the novel YghJ protein. Predicted functional domains are
indicated. The curved line indicates the putative lipobox. The amino acid sequence
LAGCD is an LOL pathway avoidance signal contained in the lipobox. DUF4092 is a
domain of unknown function. The M60-Like domain is a putative metallopeptidase
domain with mucinase activity. Figure is not drawn to scale.
Blast analysis also indicates a M60-like domain (Pfam 13402) from amino acid
1081 to 1381 (alignment shown in Figure 11). This domain is related to the Enhancin

peptidase family, which was originally identified from the invertebrate insect pathogen
51

Baculovirus. Baculovirus enhancin proteins possess mucin degrading activity both in vivo
and in vitro. The mucin degrading activity of this protein enhances Baculovirus infection
of Lepidopteran insects (Wang and Granados, 1997b). This domain contains two
HEXXH zinc binding motifs and has metallopeptidase activity (Wang and Granados,

1997a). The HEXXH motif forms an alpha helix in which the two histidine residues
coordinate a zinc ion in the active site of the enzyme (Fukasawa et al., 1999). Recently

the M60-like containing protein BT4244 was purified from the human gut mutualist
Bacteroides thetaiotaomicron and shown to have mucin degrading activity (Nakjang et
al., 2012).
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4-

Figure 10. Multiple sequence alignment of the DUF4092 domain of YghJ with similar proteins. Alignment was performed using
ClustlW 18.1 (Thompson et al. 1994) using Eshcerichia coli YghJ as a prototype. Identical residues are shown with a red background,
while similar residues are indicated by a red letter. Conserved motifs are surrounded by a blue box.Species names and accession
numbers are as follows: Escherichia coli YP026189.1, Escherichia coli Q707L9, Vibrio fischeri Q5E705, Vibrio vulnificus Q8DE36,
Vibrio mimicus ZP_05718328.1, Vibrio cholerae ZPO1949281.1, Vibrio parahemolyticus ZP_01988669.1, Shewanella halifaxsensis
YP 001675698.1.

When treated with EDTA, the capacity of the protein to degrade mucin was
reduced. This indicates that the metal binding domain is necessary for protein function.
Using the CLUSTALW 18.1 multi-alignment software YghJ was aligned with several

M60-like metallopeptidases, including BT4244 (Figure 8). The YghJ protein has the
conserved [HEVGH] domain at amino acid 1,303 through 1,307.

Putative Protein phosphatase 2C Domain- Amino acid sequence analysis
of the YghJ protein using the Simple Modular Architecture Research Tool (SMART)
protein database tools (Schultz et al., 2000) revealed the presence of a putative serine
threonine phosphatase domain which is related to the protein phosphatase type 2C
(PP2C) superfamily (Figure 12). Protein phosphatase 2C type enzymes remove inorganic
phosphate groups from phosphorylated proteins, typically from serine or threonine
94-

residues. The PP2C family, also known as the PPM family, is comprised of Mg or Mn

9+

dependent protein phosphatase class of enzymes (Casadaban et al., 1980). The PP2C
enzymes are exemplified by the human PP2C protein that possesses 11 distinct functional
9+

motifs that allow coordination of a divalent metal cation such as Mg /Mn

9+

crucial for

the removal of the phosphate group from proteins phosphorylated on serine or threonine
residue (Das et al., 1996). This enzyme family is distributed across all kingdoms of life,
with members found in eukaryotes, prokaryotes, and archaea. Despite the divergence
between members of this family, several conserved motifs are recognized in PP2C
proteins.
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Figure 11. Multiple sequence alignment of the M60-likedomain of YghJ with similar proteins. Alignment was performedusing
ClustlW 18.1 (Thompson et al. 1994) Bacteroidesfragilis lipoprotein as a prototype. Identical residues are shown with a red
background, while similar residues are indicated by a red letter. Conserved motifs are surrounded by a blue box. The zinc binding
motif HEXXH is surrouned by the green box.The foil species names and protein accession numbers are as follows : Vibrio cholerae
ZP 06941093.1, Bacteroides thetaiotaomicron NP813155.1, Trichomonas vaginalis XP 001330191A,Akkermansia muciniphila
YP_001878116.1, Escherichia coli YP026189.1

See Figure 12 of the ClustalW 18.1 multialignment software we generatedthat shows
these conserved motifs. The motifs include important amino acid residues (Das et al.,

1996) and a conserved secondary structure which yield a characteristic P(3(3aap repeat
motif (Bork et al., 1996). A comparison of this region, along with approximately 100

amino acids of flanking sequence on either side of the PP2C region revealed that several

of the most importantmotifs are present in YghJ. There are eleven important motifs used
to predict the PP2C domain yet only 7 of them possess any conserved amino acid
residues; these are motifs 1, 2, 4, 5, 8, and 11. The amino acid residues found in the

remainingmotifs are not well conserved and the similaritiesbetween the PP2C domains
can only be observed in the secondary structure of these domains. In addition to the
recognized motifs, as mentioned above, (Das et al., 1996) identified an arginine residue at
approximately position 33 of the PP2C domain of the prototype human PP2Ca. This
residue is important in catalysis and is conserved in YghJ. An aspartic acid at

approximately position 40 of the human PP2Ca (Motif 1), an aspartic acid at

approximately residue 65 (Motif2), and aspartic acid (Motif 8) are believed to coordinate
the metal. Motifs 4 through 7 are indicated on the figure but the role of these residues is
unknown. At Motif 11, a conserved aspartic acid residue followed by an asparagine
residue located at about position 440 is changed in YghJ and this small change may
indicate a different metal binding capability (Huang et al., 1997).
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Figure 12. Multiple alignment of the PP2C superfamily showing the 11 conserved motifs. The alignment was constructed using
CLUSTALW 18.1 (Thompson et al. 1994) with PP2Ca, Homo sapiens protein phosphatase 2C isoform a, Accession No. P35813 as
the prototype. The first column contains the protein code: PppA, Pseudomonas aeruginosa protein phosphatase A, Accession No.
NP_248765; PphI, Myxococcus xanthus protein phosphatase I, Accession No. ABF93082; slll771, Synechocystis sp. PCC6803 protein
phosphatase A, Accession No. BAA17671; PrpZ, Salmonella typhii strain CT18 protein phosphatase 2C, Accession No. CAD06946;
YghJ, Escherichia coli predicted lipoprotein , Accession No. Q46837; SpoIIE, Bacillus subtilis stage II sporulation protein E,
Accession No. P37475. Residues conserved between proteins are shown in red, residues with high homology are shown in blue,
hydrophobic residues are shown in green. The arrow indicates an arginine thought to be important in catalysis. The alignment is given
as 11 motifs numbered along the top and indicated by a red box. Motifs: #1 (D), #2 (DG), #4 (G-T), #5 (GD), #6 (G), #7 (P), #8 (DG),
#11 (DN). The secondary alignment was constructed independently for each protein using the PREDATOR alignment tool (Frishman
and Argos, 1996). The secondary sequence prediction is immediately beneath each protein: H/h=Helix, e=Sheet, c=Coil.

In Gel Assay to Testfor PP2C Activity ofthe YghJprotein-

The 4-methylumbelliferyl phosphate (MUP) substrate fluoresces after the
substrate is dephosphorylated. So MUP was used in an in-gel format for in situ detection
of PP2C activity. The in-gel assay was used to determine if the YghJ protein possessed

PP2C activity. YghJ was expressed from the high copy number plasmid called
PCB2YghJ and the gene was under control of its native promoter. The positive control
was the known PP2C protein Peptidylprolyl Isomer (PIAI) [Accession# AEV61503.1]

from Pseudomonas aeruginosa. Protein lysates were prepared and separated by native

polyacrylamide gel electrophoresis. Then proteins were renatured in the gel before being
incubated with MUP for 15 minutes. Results are seen in Figure 13. The fluorescent bands

seen in each of the E. coli samples are alkaline phosphatase. No other fluorescent bands
are seen in the strain with the pCB2YghJ plasmid which indicates that YghJ may not
possess PP2C activity. The fluorescent band seen in the P. aeruginosa sample is the 20.1
kDa PpiA protein.
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Figure 13. Assay for PP2C acivity of the YghJ protein. Samples were incubated with the
fluorogenic substrate MUP for 15 minutes before being analyzed. The positive result in
Lane 5, indicated by the arrow, contains the PPIA protein from P. aeruginosa, a known
PP2C.

Analysis of a YghJ null mutant

Construction oftheyghJ null mutant-A knockout of the yghJ gene in the
Escherichia coli strain BW25113 was obtained from the Keio collection (Baba et al.,

2006). E. coli BW25113 is related to E. coli strain K12 substrain MG1655; both strains
carry homologs of yghJ. The E. coli K12 DHa is also related to BW25113 and MG1655
but carries a variant ofyghJ which contains a sizable deletion (Lukjancenko et al., 2010).
The Keio collection mutants were created using the FLP recombinase system. PCR

products containing a kanamycin resistance cassette were flanked by FLP recognition
targets around 50-bp homologies to the desired chromosomal sequences. These
constructs were inserted into the genome using the Lambda red recombinase system
62

(Datsenko and Wanner, 2000). The cassette was then excised using the FLP recombinase.
This procedure created an in-frame deletion of the gene from the second codon removing
intervening DNA except the terminal seven codons from the 3'-end of the gene. The start
codon and the translational signal for any downstream genes are left intact.

Capacity ofthe YghJknockout mutant to metabolize different carbon

sources-To determine a phenotype for the yghJ deletion mutant, growth studies were
done in minimal media with a specified carbon source. Bacteria were grown in batch
culture with the sole carbon source indicated. A closed system was used, meaning that the

only sugar available to the bacteria was added at the initial inoculation, and was depleted
over the course of the study. Figure 14 shows the growth rate of the wild type BW25113

compared to the YghJ null mutant in M9 minimal media supplemented with 0.1%
glucose over 24 hours. The YghJ null mutant exhibits no significant difference in growth
rate with glucose as the sole carbon source. A lag of approximately 5 hours was observed
before an exponential growth phase began which lasted for 8 hours. Stationary phase
lasted until approximately 20 hours, before the bacteria began to die; likely due to the
depletion of the glucose. Other common carbons sources were also tested. Figure 15

shows a growth curve comparing the wild type strain and the YghJ null mutant over 12
hours in M9 minimal media containing 0.1 % fomarate, a 4-carbon sugar. No significant

difference in growth rate was observed.
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Figure 14. The YghJ null mutant exhibits a normal growth phenotype when grown on
M9 minimal media containing 0.1 % glucose as the sole carbon source. Strains were
grown at 37° C with shaking.
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Figure 15. The YghJ null mutant exhibits a normal growth phenotype when grown on
M9 minimal media with 0.1% fomarate as the sole carbon source. Strains were grown at
37° C with shaking. Error bars indicate standard error of the mean
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The mutant was tested for its ability to grow on 0.1% succinate (Figure 16). The

YghJ null mutant grew as well as the wild type strain did on fomarate and succinate but
the overall cell mass was significantly reduced when bacteria were grown on these poor
carbon sources. For example, lag phase was approximately 5 hours long and log phase
lasted for only about 4 hours before stationary phase was achieved.
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Figure 16. The YghJ null mutant exhibits a normal growth phenotype when grown on
M9 minimal media containing 0.1% succinate as the sole carbon source. Strains were
grown at 37° C with shaking. Error bars indicate standard error of the mean.

In contrast, the yghJ null mutant grown in M9 minimal media with 0.1% malate
as the sole carbon source exhibited a severe growth deficiency. The mutant strain grew to
an OD600 nm of ~0.2 after 4 hours and the cell mass remained stationary at that level for

24 hours. The wild type strain grew at the normal rate, entering exponential growth phase
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between 4-5 hours and stationary phase after 9 hours. The cell mass of the population
began to decline after 20 hours (Figure 17).
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Figure 17. The YghJ null mutant exhibits a deficient growth phenotype when grown on
0.1%) L-malate as the sole carbon source. Strains were grown at 37° C with shaking.
Error bars indicate the standard error of the mean.

Complementation oftheyghJ null mutant-The YghJ null mutant of
BW25113 was complemented by replacement of the YghJ protein by expression of the
protein in trans from the pCRB2YghJ plasmid. This clone contained the foil length yghJ
gene as well as the intergenic space between yghJ and the upstream glcA gene and the

downstreampppA gene. No induction was used because the pCRB2YghJ construct
contains the native promoter region, as well as any other regulatory regions present
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outside the open reading frame upstream of the gene itself. Figure 18 is representative the
complementation results obtained. The lag phase of the wild type strain was

approximately 5 hours and exponential phase lasted for 8 hours, reaching an OD600 nm

of-0.7. The YghJ null mutant did not obtain any significant growth; growth was blocked
at an OD600 nm of-0.2. The growth defect in 0.1% malate was complemented by

expression of YghJ from plasmid pCB2yghJ. The complemented mutant grew
significantly better than the YghJ null mutant, after a lag of 5 hours reaching an OD600
nm of- 0.6 after 12 hours; exponential growth phase lasted for about 11 hours.
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Figure 18. The YghJ null mutant is able to partially recover growth in 0.1% L-malate
when complemented with the yghJ gene expressed from a high copy number plasmid.
Strains were grown at 37° C with shaking. The strain containing pPCRyghJ was grown in
ampicillin at 100 jag/ml.
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Expression and attempts to purifiy the YghJ-6xHis fusion protein

Expression of YghJfrom an inducible vectorpBAD202D/TOPO expression vector

The open reading frame of the yghJ gene was cloned into the arabinose inducible
expression vector pBAD202D/Topo vector (Invitrogen). The plasmid contains the
arabinose inducible araC promoter. Figure 19 shows SDS-PAGE analysis of the

induction study. Cultures were induced for the indicated amount of time with the
different concentrations of arabinose. No YghJ was seen in any of the samples. However,

a low molecular weight band of approximately 14 kDa was visible on the gel. This band
matches the size of the thioredoxin tag present on the carboxy-terminus of the YghJ

protein when expressed from the pBAD202D/Topo vector. The protein may have been
degraded due to improper folding leading to proteolytic cleavage of the recombinant
protein.
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Figure 19. SDS-PAGE analysis of YghJ expressed from the arabinose inducible
Pbad202D/Topo vector. Samples were separated in in a 4-12% No vex Bis-Tris gel. All
samples were induced for 6 hours with the indicated concentration of arabinose and
grown at 37 °C with shaking in the presence of 30 ug/ml kanamycin The small molecular
weight band is indicated by the arrow.
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Expression of YghJ from the pET21a vector in strain BL2UDE3)

The open reading frame of the yghJ gene was cloned into the inducible expression
vector pET21a. This plasmid contains the IPTG inducible T7 promoter. Cultures were
grown to an OD600 of 0.4 then induced with IPTG. Figure 20 shows SDS-PAGE
analysis of an induction study using various IPTG concentrations. Cultures were induced

with 50 mM, and 100 mM IPTG and grown for 8 hours; samples (1 ml) were taken at 2,
4, 6, and 8 hours. The YghJ protein expressed successfolly with both concentrations of

IPTG as protein was detected within the first 2 hours and every hour thereafter.
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Figure 20. SDS-PAGE analysis of YghJ expressed from the IPTG inducible pET21a
vector. Samples were separated in an 8% Bis-Tris polyacrylamide gel. Samples were
induced with the indicated IPTG concentration for the indicated time at 37 °C with

shaking. The arrow indicates YghJ.
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Purification of YghJusing metal affinity chromatographyPierce B-PER 6XHis Fusion Protein Purification Kit
The Pierce B-PER 6XHis Fusion Protein Purification Kit uses the Bacterial

Protein Extract Reagent to lyse cells and extract soluble proteins. After removing cellular
debris by centrifugation, the lysate was incubated with nickel chelate agarose to bind the
His-tag YghJ recombinant protein. Agarose beads were washed by centrifugation to
remove superfluous unbound proteins before the YghJ-6xHis protein was eluted using
imidazole. Figure 21 shows the result of the purification attempt. The protein was eluted
in 4 fractions that were pooled before being analyzed by SDS-PAGE. Lane 1 contains the
molecular weight marker. Lane 2 contains the induced lysate before reaction with the

nickel chelate agarose. The YghJ-6xHis protein is present at high levels, indicating a
successful induction. Lane 3 contains the flow-through obtained after the YghJ-6xHis

recombinant protein was reacted with the nickel chelate agarose. A large amount of YghJ

is present in the flow-through, which means that YghJ-6xHis did not stick well to the
nickel chelate agarose. Lanes 4-6 are the column washes. A small amount of YghJ-6xHis
is visible in the first wash, but no YghJ-6xHis is visible in the proceeding washes. Lanes
7-10 are the elution fractions. Proteins were eluted into a 1 ml volume of elution buffer

and 20 ul were loaded onto the gel. No YghJ-6xHis is visible in any of the elution
fractions because the protein did not stick to the nickel chelate agarose.
To potentially improve the stability of the YghJ-6xHis protein, the antioxidant 2-

mercaptoethanol was added to the lysis buffer, wash buffer, and elution buffer before

purification. The lysate was purified as above and the results can be seen in Figure 22.
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Lane 2 contains lysate that with the induced YghJ-6xHis protein. Lane 3 contains the
initial flow-through. Again, a large amount of YghJ-6xHis is seen in the flow-through but
none is seen in any of the washes or elution fractions.
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Figure 21. SDS-PAGE analysis of an attempted purification of YghJ-6XHis using the
Pierce B-PER 6XHis protein purification kit. Samples were separated in in a 4-12%
Novex Bis-Tris polyacrylamide gel. The arrow indicates YghJ. All proteins appear to be
present in the flowthrough.
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Figure 22. SDS-PAGE analysis of an attempted purification of YghJ-6XHis using the
Pierce B-PER 6XHis protein purification kit containing 5 mM p-mercaptoethanol.
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Samples were separated using an 8% Bis-Tris polyacrylamide gel. The arrow indicates
YghJ.
Clonetech HisTALON Gravity Purification Columns

Clonetch HisTALON Gravity Purification Columns replaced the other matrices to

see if YghJ-6xHis would stick better to this column. These columns used a cobalt chelate
agarose as opposed to the nickel chelate agarose in the Pierce kit which is reported to be

more effective. The protein was reacted with the column then washed using gravity rather
than centrifugation. We first attempted to purify YghJ-6xHis using the B-PER buffer
from the Pierce kit above. A 100 ml culture was lysed overnight in B-PER buffer before

being applied to the column. The column was washed four times in sodium phosphate
wash buffer before being eluted with 100 mM imidazole. Figure 23 shows an SDS-PAGE

gel analysis of the attempted purification. Lane 1 contains the induced YghJ fraction.
Lane 2 contains the flow-through from the column. Lanes 3-5 contain the washes. Lanes

6-8 contain elution fractions. Again, most of the YghJ protein is seen in the initial flowthrough fraction, meaning that the YghJ-6xHis fusion protein did not bind to the column.
However, a smaller protein is visible in the elution fractions, meaning either some non
specific binding occurred or that the protein of interest was breaking down on the
column.

To ensure that YghJ-6xHis was fully denatured and no other proteins were binding and
blocking access to the 6XHis epitope, the lysate and buffers were treated with 0.1%
Triton-X 100 detergent. Purification was performed as above, and the results can be seen
in Figure 24. Lane 1 contains uninduced sample, Lane 2 contains induced YghJ-6xHis
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and Lane 3 contains the flow-through from the column. An almost equal amount of YghJ
is seen in the induced fraction as the flow-through, indicating that YghJ-6xHis did not
stick to the column. The elution fractions in lanes 8-10 again contain the smaller
unknown protein.

260

Figure 23.SDS-PAGE gel analysis of a purification performed using the Clonetech
HisTALON Gravity Purification Columns. The samples were lysed using the Pierce
Bacterial Protein Extraction Reagent. Samples were separated in an 8% Bis-Tris
polyacrylamide gel. The arrow indicates YghJ.
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Figure 24. SDS-PAGE gel analysis of YghJ purification using the Clonetech HisTALON
Gravity Purification Columns. Samples were separated in in a 4-12% Novex Bis-Tris
polyacrylamide gel. Samples were lysed in the the Pierce B-PER buffer containing 0.1%
Triton-X 100. The arrow indicates YghJ.

The Talon xTractor buffer can be used to extract membrane bound proteins. The
manufacturer recommends the use of lmg/ml lysozyme combined with 1 ug/ml DNAse I

for the extraction of membrane bound proteins. Figure 25 shows the results of a
purification using these recommended reagents. Again, a similar amount of YghJ-6xHis
is seen in the lysate and flow-through, while the unknown smaller protein is present in the
elution.
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Figure 25. SDS-PAGE gel analysis of YghJ purification using the Clonetech HisTALON
Gravity Purification Columns. Samples were separated in in a 4-12% Novex Bis-Tris
polyacrylamide gel. Samples were lysed in the the Clonetech xTractor buffer containing
1 ug/ml DNAse I and 1 mg/ml lysozyme. The arrow indicates YghJ.
Invitrogen Dynabeads His-Tag Isolation Beads

The Invitrogen Dynabeads are a cobalt magnetic chelate that binds histidinetagged proteins. Beads are incubated in the lysate and removed using a magnetic system.
A 100 ml lysate was prepared using the Talon xTractor buffer containing lysozyme and
DNAse I. The lysate was incubated with the Dynabeads for 2 hours before the beads were
removed from the lysate using a magnet and washed 3 times using a sodium phosphate
buffer. Bound proteins were eluted from the beads using a sodium phosphate buffer
containing 100 mM imidazole. Figure 26 shows the results of this purification. Lane 5 is
the induced lysate containing the YghJ-6xHis protein before any purification. Lane 6
contains the lysate which was removed from the beads after the 2 hour incubation period.
Lanes 9-11 contain the three wash fractions, while lanes 1-4 contain the elution. Little to
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no YghJ-6xHis is seen in the elutions, meaning that YghJ-6xHis did not successfully bind
to the Dynabeads. The uninduced fraction is in the final lane.
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Figure 26. SDS-PAGE gel analysis of YghJ purification using Invitrogen Dynabeads
His-Tag Isolation Beads. Samples were separted in a No vex 4-12% Bis-Tris
polyacrylamide gel. Samples were lysed in the the Clonetech xTractor buffer containing
1 ug/ml DNAse I and 1 mg/ml lysozyme. The arrow indicates YghJ.
Immunoblot to detect the YghJ-6xHis recombinant protein- To

determine if the 6XHis tag was available for binding to the nickel or cobalt columns we
attempted to use for purification, an immunoblot was done using two antibodes specific
to the 6XHis tag. An induced lysate was separated by SDS-PAGE then transferred onto
nitrocellulose and treated with antibody specific to the 6XHis epitope. No protein was
detectable with the commercially available India anti-His HRP conjugated antibody
(Pierce) or the Covance anti-His antibody (Covance). A control immunoblot was

performed using the same procedure with the YhcM-6XHis tagged fusion protein. The

YhcM-6XHis protein is another protein we discovered and cloned into the pET21a
expression vector and purified using the Dynabeads. Both antibodies successfully
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detected the 47 kDa fusion protein (Data not shown); which shows that the reagents are
functional and the techniques used were appropriate.

Localization of YghJ

Membranefractionation of YghJ- To test the hypothesis that YghJ is
localized to the inner membrane by virtue of its predicted inner membrane localization
signal sequence, the inner and outer membranes of the bacteria were separated by

ultracentrifugation and the inner membrane proteins solubilized with Triton-X 100. The
results are shown in Figure 27. The strain BL21(DE3)carrying pETMGORFYghJ was
used. The strain was induced for 6 hours before separation was done. The uninduced
sample was untreated with IPTG. After separation by ultracentrifugation, the majority of
the induced YghJ is in the inner membrane fraction, indicating that YghJ preferentially
localizes to the inner membrane (lane 2). Small amounts of YghJ were detected in the cell
fraction liberated after sucrose treatment and sonication; this fraction contains cytoplasm
and periplasmic proteins. The small amount of YghJ seen is probably nascent YghJ

protein that had not anchored to the inner membrane (lane 6). No YghJ was visible in the
outer membrane fraction (lane 4). As expected, YghJ was not seen in any of the fractions

from the uninduced samples.
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Figure 27. SDS-PAGE gel analysis of membrane fractionation of YghJ. Samples were
separated in an 8% Bis-Tris polyacrylamide gel Lane 1: Molecular weight marker Lane
2: inner membrane fraction induced with IPTG. Lane 3: Uninduced inner membrane
fraction. Lane 4: Uninduced outer membrane fraction Lane 5: Induced soluble fraction

Lane 6: Uninduced soluble fraction The arrow indicates the position of YghJ.
Globomycin Treatment of YghJ- The putative signal sequence spanning

the first 23 amino acids of YghJ includes a predicted lipobox sequence. This sequence is
cleave by the signal peptidase II LspA in the periplasm before being lipidated and the
proteins anchored in the membrane. To test the hypothesis that YghJ is lipidated, the
protein was treated with the antibiotic globomycin. The antibiotic globomycin
specifically inhibits the signal peptidase II enzyme LspA, which cleaves the nascent
prolipoprotein at its diacylglycerol modified cysteine residue (Wu et al., 1983) leaving

the first 23 amino acids attached to the protein and stops the addition of the final acyl
group onto the protein. This results in a longer protein which will not anchor in the
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membrane. After treatment with nonlethal concentrations of globomycin, two species of

all lipoproteins in the cell are present including YghJ.

160-

Figure 28. SDS-PAGE analysis of globomycin treated BL21 (DE3) expressing the YghJ
protein from the induced pET21a vector. Samples were separated in an 8% Bis-Tris
polyacrylamide gel Samples were treated with the increasing concentrations of
globomycin: 50 mM, 100 mM, and 200 mM for 3 or 6 hours. The arrows indicate the two
variants of the YghJ protein.

E. coli strain BL21(DE3)pETMGORFYghJ.7 containing the yghJ gene on the
IPTG inducible pET21a vector was used to perform the experiment. The strain was

induced for one hour before treatment with the indicated concentration of globomycin,
then grown for three hours and analysed by SDS-PAGE (Figure 28). The uninduced
sample contained no YghJ (lane 2) and the induced sample which was NOT treated with
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the antibiotic contained YghJ of the proper molecular weight (lane 3). As the
concentration of globomycin increased, a second YghJ variant became visible on the gel,

most evident in the 200 mM globomycin treated sample (lane 6). The increasing amount

of the smaller variant indicates that YghJ is nonlipidated in presence of globomycin. The
generation of the smaller variant during globomycin treatment indicates that under

normal conditions the YghJ protein is lipidated.

Comparison of growth of STEC 091:H21 and STEC 0157:H7 in Minimal
M9 Media with L-malate as Sole Carbon Source

The YghJ protein was initially identified through a proteomics screen to identify
differential protein expression in the LEE-positive STEC 0157:H7 strain 86-24 and the
LEE- negative STEC 091:H21 strain B2F1. The LEE-positive strain lacked the yghJ
gene but the LEE-negative strain B2F1 carried the yghJ gene and expressed the protein
under normal laboratory conditions. Once we knew the YghJ null mutant was deficient
for growth on L-malate, we tested the wild type LEE-positive STEC 0157:H7 for its
capacity to utilize L-malate as the sole carbon source. See results in Figure 29.

YghJ positive STEC 091 :H21 grew much more efficiently on L-malate compared
to yghJ-negative STEC 0157:H7. STEC 091 :H21 reached exponential growth phase

after 4 hours and entered stationary phase after only 8 hours. STEC 0157:H7 had an
extended lag phase of 13 hours delay as compared to STEC 09LH21. STEC 0157:H7
did not reach stationary phase until 22 hours. STEC 0157:H7 recovered after the lag
phase and reached a similar cell mass at stationary phase once growth resumed.
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Figure 29. The YghJ negative pathogenic STEC 0157:H7 strain 86-24 exhibits a
deficient growth phenotype compared to the YghJ positive STEC 091 :H21 strain B2F1
when grown on 0.1% L-malate as the sole carbon source. Error bars indicate the standard
error of the mean.
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Expression of Enterohemolysin

EhxA production on SRBC agar- Detection of enterohemolysin activity
by wild-type strains of LEE-positive and LEE-negative STEC organisms requires that

the sheep red blood cells added to the agar are pre-washed and the agar plates are
incubated overnight until small turbid zones of hemolysis around colonies are evident.
Clear hemolytic halos were seen around the colonies of 34.7, and these zones of
hemolysis were much larger than those associated with B2F1. The amount of EhxA
activity detected in Figure 30 is greater in 34.7 than that detected for the parental strain.

Figure 30. Comparison of enterohemolytic phenotypes on SRBC agar. Bacteria tested
are individually labeled above each panel. Cultures were applied to tryptose agar that
contained 5% washed sheep red blood cells and 10 mM CaCl then incubated at 37°C in a
5% C02 atmosphere for 18 hours.
To determine if transcriptional regulation of the ehx operon required
chromosomal genes unique to STEC 091 :H21, the large plasmid (pB2Fl) was

transferred into the non-pathogenic and non-hemolytic E. coli K-12 laboratory strain
DH10B. As seen in Figure 30, the hemolytic phenotype of DH10B (pB2Fl) is

comparable to that noted for wild-type STEC 091 :H21 as indicated by the similarity in
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size of the turbid hemolytic halos around STEC 091 :H21 and DH10B (pB2Fl). These
results suggested that the ehx operon present on the large plasmid is regulated in a like
manner, whether in the STEC 091:H21 or DH10B background.

To determine if an increase in copy-number of ehxCABD would affect the amount

of EhxA produced, we cloned the ehxCABD operon, including 88 bp of DNA upstream of
the ehxC start codon that we surmised contains the promoter region, onto the high-copy
number vector pCRScript Amp SK (+) to create pCRe/w:. This plasmid construct was
then moved into DH10B. The level of hemolysis was comparable to that seen for DH10B
(pB2Fl) and STEC 091 :H21 (Figure 30). These results suggest that the expression of the
ehx operon is under strict control since the presence of multiple copies of the operon, as
in the case of DH10B (pCRe/oc), within the bacterial cell did not result in a detectable
increase in hemolytic activity. These findings further implied that there were no other
genes present on the plasmid of pB2Fl required for regulation of ehx and that a
chromosomal factor found in both strain STEC 091 :H21 and DH10B was involved in

ehx regulation.

We then investigated whether HNS might be the major factor involved in ehx
regulation. To accomplish this aim, we transferred the multi-copy number plasmid
ipCRehx into strain THK62. This is a non-pathogenic, non-hemolytic laboratory strain of

E. coli that contains a tetracycline antibiotic insertion that disrupts the functionality of

hns (Donato et al., 1997). The hns mutant THK62 (pCRehx) reverted from non-hemolytic
to a hemolytic phenotype, as evidenced by large and clear hemolytic halos on SRBC agar
(Figure 30). The hemolytic activity detected is comparable to that noted for 34.7. Taken
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together, the data indicate that lack of the HNS protein resulted in de-regulation of ehx

expression and that plasmid-copy-number does not play a significant role in how much
active hemolysin is detected on SRBC agar.

Comparison ofEnterohemolysin levels in theHNSknockout mutant 34.7To determine whether more EhxA was made or whether more was

secreted by strain 34.7, the relative amounts of EhxA protein present in the supernatants
of cultures, within the cell and on the cell membrane were evaluated. Log-phase cultures

of 34.7 and STEC 091 :H21 were pelleted and supernatants recovered and set aside for

analysis (supernatant was designated as [S]). Pelleted bacterial cells were re-suspended in
fresh media and then disrupted by sonication. The resulting lysate that contained

membrane, cytoplasmic and periplasmic proteins was concentrated by centrifugation and
designated as pellet [P]. Proteins in the pellet lysates and the supernatant samples were

precipitated with trichloroacetic acid. The negative control consisted of the plasmid-cured
derivative, SI 1, of the parental strain STEC 091 :H21 which is e/zx-negative by virtue of
the loss of the plasmid (Scott et al., 2003). The positive control strain was E. coli
WAF100 (pSF4000) (Welch and Falkow, 1984). Plasmid pSF4000 carries the a-

hemolysin operon (hlyACBD) originally cloned from the pathogenic urinary tract isolate
of E. coli strain J96 (Welch et al., 1983). Previous reports indicate that HlyA is 110 kDa
and EhxA is approximately 107 kDa (Felmlee T et al., 1985) (Schmidt et al., 1995).
Figure 31A shows the results of SDS-PAGE gel analysis when enterohemolysin

was detected by colloidal blue stain. In Figure 31A the horizontal arrow indicates
migration of the HlyA protein in 4-12% gradient gels whereas the star points to the
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position of the EhxA protein. Lane 1 Figure 31A contains the HlyA protein presentin the
supernatant of WAF100 (pSF4000) while lane 2 represents membrane associated HlyA
contained in the pellet fraction. Lane 2 Figure 31A contains the supernatant fraction
recovered from 34.7 cultures. Lane 6 Figure 31A contains the supernatant fraction
recovered from STEC 091:H21.

Comparison ofEhxA recovered from the supernatant fractions of 34.7 and STEC
091:H21 revealed that 34.7 secreted more enterohemolysin than did STEC 091:H21;

lanes 3 and 6 of Figure 31A respectively. It is typical that wildtype STEC secrete little

enterohemolysin (Chart et al., 1998). No cell-associated EhxA was detected in pellet

samples of 34.7 run on colloidal blue-stained SDS-PAGE gel (31A lane 4). A star marks
the migration of EhxA detected in the pellet fraction of STEC 091:H21 (Figure 31A lane
7).
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Figure 31. Analysis of representative levels of enterohemolysin produced by different
strains. Samplesmarked with an (S) or (P) stands for supernatant and pellet; respectively.
(A) SDS-PAGE gel comparison of enterohemolysinproduced by wild-type strains
versus the hns mutant. Various strains are listed across the top of the gel. The horizontal

arrow points to the a-Hly protein which migrates at 110 kDa and the star points to the
enterohemolysin present in both 34.7 and B2F1. The positions of the molecular weight
markers in lane 7 are indicated. The arrowhead marks migration of FliC protein present

in B2F1 and SI 1 but absence in 34.7. (B) Western blot analysis of extracellular
enterohemolysin. All lanes contain supernatants recovered from samples analyzedby
SDS-PAGE gel shown in panel A. Immunoblot of the supernatants were run at the same
time as the SDS-PAGE gels. Molecular weight protein markers are indicated on the gel.

SDS-PAGE gel analysis suggests that the amount of EhxA secreted by 34.7 exceeded that
of STEC 091 :H21. Note that the level of EhxA produced and secreted by STEC

091 :H21 is quite low and difficult to detect by colloidal blue stain. As expected no Ehx
was detected in any of the plasmid-cured SI 1 samples (Figure 31A lanes 8-9). Bacterial
cultures were equalized prior to SDS-PAGE gel and Western blot analysis. The protein

profile of the hns mutant, 34.7, is somewhat different from the parental strain and is due
to a change in protein expression as a result of the hns defect. This difference is
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exemplifiedby the lack of FliC protein in 34.7. In contrast, the FliC protein is detected in

the supernatant of STEC 091 :H21 and SI 1. The migration of the FliC protein is denoted
by an arrowhead in STEC 091:H21 and SI 1 samples; lanes 6 and 8 respectively. The
absence of flagella in E. coli isolates that have knockouts in the hns gene has been noted
by other investigators (Berlin et al., 1994).

Immunoblot analysis ofEhxA secreted by theHNS null mutant, 34.7-

EhxA as well as HlyA belong to the repeat in toxin (RTX) family of toxins and

hemolysins HlyA and ApxII are most closelyrelated to EhxA (Bauer and Welch, 1996).
Members of this family including the HlyA of E. coli and the adenylate cyclase-

hemolysin (CyaA) of Bordetella pertussis show genetic relatedness and antigenic

similarity. Some anti-CyaA monoclonal antibodies cross-reactwith EhxA within an
invariantregion of the protein called the nonapeptide repeat region (Bauer and Welch,
1996). Commercially available antibody CyaA(9D4):sc-13581 specific for the adenylate

cyclase-hemolysin (CyaA) was shownto cross-react with EhxA (Bauer and Welch,
1996). Therefore, we used the CyaA(9d4):sc-13581 antibody to detect the presence of
EhxA in culture supernatants. Previous reports indicate that the EhxA protein runs on
SDS-PAGE gels as an -107 kDa protein band (Brunder et al., 2006). The same

supernatant samples analyzed by SDS-PAGE and shown in Figure 30A were used in
Western blot analysis. In Figure 3IB lane 5 the positive control HlyA protein known to

migrate to 110 kDa molecular weight and correlates with the EhxA protein known to be
of similar size (Figure 3 IB lane 4) (Felmlee T et al., 1985) (Schmidt et al., 1995). The
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Western blot confirms the SDS-PAGE results that showed a band similar in size to HlyA

which corresponds to EhxA. Taken together the SDS-PAGE gel and the Western blot
analysis indicate that 34.7 produced and secreted more enterohemolysin than did the

parental wild-type strain, STEC 091.H21. The small amount ofEhxA secreted by STEC
091 :H21 and detected with colloidal blue stain was not picked-up by the cross-reacting

primary antibody (lane 3 of Figure 3IB). As expected, no EhxA protein was noted in
samples of plasmid-cured SI 1 (Figure 3IB lane 2).
Relative enterohemolysin activity in culture supernatants of34.7 versus
STEC 09LH21- To quantify the relative amount of EhxA activity

present in supernatants recovered from the hns mutant 34.7 as compared to STEC
091.H21, a standard hemolysis tube assay was done with supernatants recovered from

log-phase cultures (Welch et al., 1983). The a-hemolysin protein expressed by WAF100

(pSF4000) served as the positive control strain for cytolytic activity and DH10B that
contained the vector without the insert was the toxin-negative control (Figure 32A). With

this standard hemolysis tube assay, no hemolytic activity was measurable in bacterial

supernatants recovered from the wild-type strain STEC 091.H21. Likewise, culture
supernatants from DH10B (pB2Fl) which contained the large plasmid that encodes the
ehx operon transferred from STEC 091 :H21 was non-hemolytic in the tube assay. These
results suggest that HNS repressed the level of enterohemolysin produced by STEC
091 :H21 and DH10B (pB2Fl). Similarly, other investigators have reported that STEC
0157:H7 organisms secreted only trace amounts of enterohemolysin into the surrounding
media during growth (Chart et al., 1998).
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In contrast, in the HNS deleted background of strain 34.7, the level of

enterohemolysin activity detectable in the supernatants increased considerably such that
an undiluted sample of culture supernatant yielded approximately 70%> lysis in a standard

tube assay and activity persisted (at ~15%o lysis) even when supernatants were diluted 1:8
as shown in Figure 29. Similarly, as depicted in Figure 32B, when plasmid pCRehx was
moved into the hns knockout, THK62, the culture supernatant contained high levels of

enterohemolysin activity (undiluted sample was capable of 90%> lysis) comparable to that
of 34.7. In sum, the results suggest that it is the presence of the HNS protein that

represses transcription of the ehxoperon. Furthermore, the multi-copy plasmid pCRehx
carried by DH10B (wild-type for HNS) did not produce and transport enough
enterohemolysin out of the cell to be detectable in the tube assay (Figure 32B). The tube
assay data supports the SDS-PAGE gel and Western blot analyses of supernatants
recovered from STEC 09LH21 and 34.7 (Figure 31A and 3IB). The data indicates that

the amount of EhxA protein secreted by STEC 091 :H21 cultures is low when compared
to 34.7 and suggests that the production of enterohemolysin is regulated.
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Figure 32. Hemolytic tube Assay: Comparison of extracellular hemolytic activity present
in supernatants recovered from cultures of wild-type strains and hns mutants. Panel A:
The samples of supernatants recovered from each bacterial isolate were used as undiluted
(un), serial 2-fold dilutions (1:2); (1:4); or (1:8), or diluted 1:50 as shown. Panel B:
Bacterial cultures were equalized and the supernatant from the logarithmic-phase cultures
recovered by centrifugation and filtered, then 2%> washed SRBC suspension was added.
The mixture was incubated for 4 hours at 37°C. Post incubation the optical density at 540
nm of supernatants was determined. Error bars indicate the standard error from the mean.
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HNS binding to the putative ehx promoter region

HNS binding assays to theputativepromoterregion ofthe ehx operon
carried by STEC 091.H21- Based on the evidence described above, we

hypothesized that the HNS protein interacts directly with the putative promoter region of
the ehxoperon to repress gene transcription. To test this hypothesis, we performed
electrophoretic DNA mobility shift assays (EMSA) at both 25°C and 37°C to determine

if temperature had a significant effect on HNS binding. The EMSAresults shown are for
reactions done at 37°C with a DNA fragment which includes 126 nucleotides just

upstream of the ehxC translational start site (Figure 33A). In addition, we ran EMSA with
a slightly smaller fragment that contained only 88 nucleotides of DNA upstream of the
ehxCstart codon. The result of EMSA with the 126 bp fragment of DNA is shown below.

The HNS-his-tagged fusion protein purified by nickel-affinity chromatography(Figure
33B lane 2) migrated to the expected size of 31 kDa. Figure 30B lane 2 is a sample of the

purityof the HNS-his-tagged fusion protein used in the electrophoresis mobilityshift
assay (EMSA).

The target DNA region, 88 bp or 126 bp upstream of the start codon of ehxC, used
in the EMSA did not include any of the ehx DNA coding sequence. A constant amount of
DNA (20uM) that contained the putative promoter region of ehx and varying
concentrations of HNS were reacted together for 30 minutes at 25°C or 37°C. The results
shown in Figure 31A are the EMSA done at 37°C with the 126 bp fragment. A

HNS:Promoter-e/zx complex with significantly retarded mobility was formed upon
addition of HNS at both 25°C (data not shown) and 37°C.
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Figure 33. Electrophoretic mobility shift assay (EMSA): Binding of HNS to the putative
promoter region of ehx from STEC 091:H21. Panel A lane 1 contains the 126bp
fragment of DNA without HNS added. Migration of 20 uM of the 126 bp fragment is
marked by an arrow labeled as F. Lanes 2 - 5 contains 0.40 uM, 0.20 uM, 0.10 uM, and
0.05 uM of HNS reacted with the 126 bp DNA fragment held constant at 20 uM. Arrow
C indicates the untreated ehx fragment that is unbound to HNS. Arrow D indicates ehx

fragment that is bound to HNS. Panel B is the colloidal blue stained SDS-PAGE gel that
contains the HNS histidine-tagged 31 kDa fusion protein recovered, shown in lane 2,
following nickel-chelating affinity chromatography. Molecular weight markers are
indicated for panel B.

B—
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Figure 34. Electrophoretic mobility shift assay to determine HNS binding to the putative
ehx promoter region of STEC 0157:H7. Lane 1 contains the putative 112 bp promoter
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region withno HNS added. Lanes 2-5 contain the same 112 bp region incubated with
decreasing concentrations of HNS; 0.40 uM, 0.20 uM, 0.10 uM, and 0.05 uM. DNA
concentration was kept constant at 20uM . Arrow A indicates the untreated ehxfragment
that is unbound to HNS. Arrow B indicates ehx fragment that is bound to HNS.

Maximal DNA/HNS complex was formed when HNS was added at 0.2 uM and

0.10 uM (Figure 33A lanes 2-3). However, when the concentration of HNS was reduced
to 0.050 uM or 0.025 uM the DNA/HNS complex begun to fall apart or did not form

(Figure 33A lanes 4-5). Both fragments of DNA that corresponded to the upstream region
of ehxC yield virtually identical results. The result suggests that the regulatory cis-acting
element which is sensitive to HNS repression lies within 88 bp of DNA upstream of the
ehxC start codon and that HNS binds this fragment of DNA at both 25°C and 37°C.

Direct binding of HNS to target DNA indicates a role for HNS regulation of transcription
offhtehx operon.

Regulation of the ehx operon in LEE-positive STEC strains is controlled by the

LEE encoded regulatory protein GrlA. However, when an identical study was performed

using the region upstream of the ehx operon from the LEE-positive STEC 0157:H7. The
HNS protein appeared to bind the same region of DNA in the same manner in STEC
0157:H7 as in STEC 091:H21. The results are shown in Figure 34.

Transcription of the ehx operon in the presence of HNS

To demonstrate that the HNS protein represses transcription of the ehx operon, a

gene fusion between the putative promoter region of the ehx operon and the promoterless (3-galactosidase gene was constructed. We observed p-galactosidase activity from
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vector pMCehxCA '-lacZ in the wild-type background (DH10B) and in the HNS null
background (THK62). Vector pMCehxCA '-lacZ contains 126 bp of DNA upstream of the
ehxC start codon along with the open-reading-frameof ehxC and includes 695 bp of the

ehxA coding region. The two E. coli strains used, DH10B and THK62 are both defective
in p-galactosidase. When plasmid pMCehxCA '-lacZ was transferred into DH10B, the
level of detectable P-galactosidase was negligible (Figure 35). In contrast, in the HNS
null mutant strain that contained the transcriptional fusion construct, THK62

(pMCehxCA'-lacZ), ~10-fold more p-galactosidase was produced as compared to THK62
without the lacZ transcriptional fusion (Figure 35). In sum, the data supports the idea that
HNS regulates transcription of the ehx operon by direct binding to DNA sequences

within 126 bp region of DNA upstream of the translational start site of the ehx operon,
that HNS binding results in suppression of transcription of the ehx operon. This 126 bp
region of contains the promoter of ehx.
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Figure 35. Effect of the hns mutation carried by THK62 on the expression of pgalactosidase from the ehxCA'::lacZ reporter gene fusion. All strains were grown to midlog phase at 37°C and assayed for p-galactosidase activity. The data is an average of
three independent experiments, with each experiment done in triplicate. The pgalactosidase activity measured as enzymatic activity/mg of protein/time. Detection was
done at a maximum absorbance at optical density 570 nm. Error bars indicate the
standard error of the mean.

Comparison of upstream nucleotide sequence of the ehx operon between
STEC 091:H21 and STEC 0157:H7

A fragment that contained 100 nucleotides of DNA upstream of ehxC and
included 516 nucleotides of the open reading frame of the ehxC gene carried by STEC
091:H21 strain STEC 091:H21 was sequenced. The large plasmid carried by STEC

0113:H21strain EH41 has been sequenced (Leyton et al., 2003) and the large plasmids
carried by four different strains of STEC have been sequenced (Brunder et al., 2006)
(Burland et al., 1998) (Makino et al., 1998). To determine if the non-coding upstream

regulatory sequences of the ehx operon cloned from strain STEC 091 :H21 was similar to
the same region of DNA in STEC 0157 we used the STEC 091 :H21 sequence as the
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query and subjected it to the Basic Local Alignment Search Tool (Blast). We found that
the region of DNA 100 bp upstream of the start codon of ehxCpresent in four different
strains of STEC 0157 was 95% identical to the same region of DNA cloned from STEC

091:H21. The alignment was virtually identical in each of the four strains of STEC 0157
with no gaps (Figure 36). The EC4115 representative 0157 strain is shown but the results
of all three 0157 isolates were similar. The boxed nucleotides are those which are

different from the sequence found in STEC 091:H21. The strains of STEC 0157:H7
identified were: EC4115, 3072/96, EDL933, and Sakai. As expected, alignment between

the related STEC 0113:H21 and 091:H21 isolates was higher at 97% with 95% of the

DNA fragments tested. An almost identical 100 bp DNA sequence exists upstream of the
start codon of ehxC in both LEE-negative and LEE-positive STEC. We showed that this

region serves as a cis-regulatory element important for HNS binding and gene
transcription in STEC, therefore we suggest that this region of DNA found in STEC
organisms function in a like manner.
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Seratype
•fSTEC

Strai-

AEg»«t af DNA Seqacace Upatreua af Start Cadaa af dbcC
-95

091.1121

B2F1

TGTTTTTAGATGCTTCTTGCTTAAAAGAATATAATTCCTGTTCTTTT

Ol111121

KH41

TGTTTTTAGATGCTTCTTGCTTAAAAGyATATAATTOCTGTTCTTTT

0157M7

KC4H5 tgtttttagatgcttcttgcttaaaag^tataattItIctgttctttt

091:1121

B2F1

ATATAGAGTTCTTTACATTTACTGAATTTTCTTATTTGTTTAAACATTATG

OH3.-H21

EH41

ATATAGAGTTCTTTACATTTACTGAATTTTCTTATTTGTTTAAACATTATG

0157JI7

EC4115 ATATAG^TTCTTTACATTTACTGAGTTTTCTTATTT{A]rTTAAACATTATG

start codon

Figure 36. Sequence alignment of the putative promoter region of ehx described for
STEC 0113:H21 strains EH41 which lies upstream of the putative translational start site
of ehxC. Significant alignments with DNA sequences derived from STEC 091:H21
strain B2F1using the Basic Local Alignment Search Tool (BLAST) database. Boxed
nucleotides are those different from strain B2F1. Matching DNA sequence carried on the

large plasmid of five different strains of Shiga toxin-expressing E. coli: 0113:H21 strain
EH41 [accession # NC007365.1]; 0157:H- strain 3072/96 [accession # NC_009602.1];
0157:H7 strain EC4115 [accession # NC_011350.1]; 0157:H7 EDL933 [accession #
NC007414.1]; and 0157:H7 strain Sakai [accession # NC_002128.11
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DISCUSSION AND CONCLUSION

Characterization of YghJ a novel protein involved in carbon metabolism and
host colonization of Escherichia coli organisms

E. coli is capable of existing in surprisingly diverse environments, thus breaking

the paradigm that E. coli exists entirely within a mammalian host. We no longer believe
that E. coli found in other environments is a consequence of fecal contamination. E. coli

associate with roots and leaves of plants, (Ibekwe et al., 2009) sands of beaches (Hartz et
al., 2008) (Hartz, A. 2008) and even in marine environments (Ibekwe et al., 2004), 2004).

What specific attributes of E. coli enhance this versatility? How can E. coli adapt to the
rigors of life in the host and to the harshness of the environment? Pathogenic strains ofE.
coli appear deceptively facile yet we have yet to break the code for how LEE-negative
STEC undertake and complete the cycle of infection within the host. We do not stay one
step ahead but are continually surprised by the rise of new vectors of infection. Prior to

my arrival, our group identified through a comparative proteomics study thirty novel
extracytoplasmic uncharacterized proteins. [Note: Extracytoplasmic proteins are defined
as proteins transported across the inner membrane with residency in the periplasm, outer
membrane or secreted from the cell.] Then using publically available functional genomics
programs we determined that ten of the proteins we identified did not fall into
recognizable functional/structural groups. Further analysis of available data allowed us to
divided these proteins into groups and recognize that ten of the thirty novel proteins had
the potential of being important in virulence.
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The YghJ protein was one of the proteins we discovered which appeared

promising. We reached this conclusion partially because in 1988 a study by Peterson and
Mekalanos reported that a transposon insertion into the acfD gene, carried by Vibrio
cholerae with -49% identity to yghJ, resulted in a V cholerae mutant defective in
colonization of the infant mouse; the accepted V. cholerae animal model (Peterson and
Mekalanos, 1988). All the information we had at the time was that the YghJ protein

resided outside of the cytoplasm and was likely membrane attached and was coded for by
LEE-negative but not LEE-positive STEC.

We determined by phylogenetic analysis that similar proteins are present not only
in E. coli and V. cholerae butyghJ-like genes are carried by a broad range of Gramnegative bacteria. Almost all of these bacteria adapt to multiple environments. For
example Vibrio sp. exists as marine symbionts, in planktonic form, as biofilm and as
infective agents within the human host. Shewanella persist in both marine environments
as well as in soil. E. coli is not typically thought of to be 'showy' pathogens like Vibrio or
Shewanella but diarrheal pathogenic E. coli like STEC typically carry large genetic
islands which allow them to colonize.

In the last six months a reverse vaccinology report involving a YghJ-like protein
shows that this protein is important in the survival of an ExPEC isolate within an animal
model (Model et al., 2010). Specifically, this group identified YghJ as a protective
antigen after animals experimentally infected with an ExPEC (pathogenic E. coli strain
causing sepsis) isolate carrying the yghJ gene [yg/zJhomolog = ECOK13385] survived
infection with little symptoms of disease (Model et al., 2010), et al.2010). This strongly
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supports our findings that YghJ provides LEE-negative STEC 091 :H21 a significant
growth advantage in poor carbon environments over STEC 0157:H7 which does not
carry yghJ. Our data together with the Vibrio and the ExPEC studies imply that YghJ is
an essential host colonization factor.

The lower large intestine in mammals is carbon limited because the majority of
carbohydrates are absorbed in the small intestine and depleted in route to the large

intestine. Due to the great array of microbes present in the large intestine the competition
is fierce for available carbon sources. The capacity to take advantage of poor and scarce

carbon sources would provide a significant advantage to bacteria within the host. We
show that the YghJ protein confers STEC 091 :H21 the capacity to utilize L-malate
efficiently outgrowing STEC 0157:H7 when grown in the same media. This advantage
could translate inside the host where YghJ will provide a competitive growth advantage

to organisms that possess it. Additionally, ex vivo L-malate is an important molecule in
the phyllosphere and rhizosphere of plants, where it functions in plant metabolism and
homeostasis (Nunes-Nesi et al., 2005). Might YghJ enable E. coli to survive and thrive on
and around plants due to a heightened ability to metabolize L-malate?
A broad shotgun protein-protein interaction study (Arifuzzaman et al., 2006)
indicates that YghJ may interact with the membrane-bound FAD-dependent malate

dehydrogenase MQO, found in the E. coli periplasm (Kretzschmar et al., 2002). We show
that YghJ localizes to the inner membrane after export to the periplasm, so it exists in the
same cellular compartment as MQO, but we have not shown any interaction between

YghJ and MQO proteins. However, our functional analysis indicates that YghJ possesses
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a putative DUF4092 domain. The DUF4092 domain is present in many inner membrane

bound lipoproteins encoded by y-proteobacteria. For example, one protein, a putative
aldehyde dehydrogenase, (Accession # C5DGE1.1) that belongs to the same superfamily
produced by Lachancea thermotloerans, contains the DUF042 domain and is involved in
carbohydrate metabolism. Not enough is known about the DUF4092 domain to

hypothesize exactly what attribute this domain provides to YghJ. The protein-protein
interaction study was crude but we were surprised by the numerous proteins that are
suspected of interacting with YghJ that contain ATP binding domains. We also noted that
the same region within the yghJ gene that overlaps with the proposed DUF4092 domain
has a rudimentary PP2C-like domain. We proposed that YghJ had PP2C activity but were
unable to demonstrate this activity; this may be because we did not have the correct
substrate or the domain may look somewhat similar to PP2C but have an entirely
different function.

The YghJ protein also possesses a putative M60-like domain. We were able to
identify by computer modeling that YghJ contained the conserved zinc binding motif
HEVGH, essential for activity. This zinc binding metallopeptidase domain was first
identified as a viral enhancin in the insect virus Baculovirus. The enhancin protein is
commonly found in gut-associated microbes and has been proven to have mucinase

activity in both the insect pathogen Baculovirus (Wang and Granados, 1997a) and more
recently found in the human gut associated microbe Bacteroides thetaiotamicron
(Nakjang et al., 2012). We are attempting to produce a cytoplasmic version of YghJ

without its signal sequence and test this construct of YghJ for mucinase activity.
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The large intestine is an environment rich in mucin which helps to form a

protective layer over the epithelial cells and limit the movement of bacteria throughout
the host. (Belley et al., 1999). Mucinase activity conferred by the M60-like domain may
enhance colonization of STEC by allowing it to penetrate the mucin layer and come into
direct contact with the host colonic microvilli, or by allowing the bacterial cells to move

more freely in the intestinal environment. Additionally, one of the major mucin subunits
is glucosamine which is also an important component of the bacterial cell wall (Hill et al.,
1992). During glycolysis, fructose-6-phosphate is generated and can be redirected to
create UDP-N-acetyl-D-glucosamine. Alternatively, D-glucosamine from the
environment can be transported into the cytoplasm of the cell by the mannose PTS
permease (Kornberg, 1975). This process results in D-glucosamine-6-phosphate and a

molecule of pyruvate. This pathway ultimately results in a molecule of UDP-N-acetyl-Dglucosamine, which can be used for peptidoglycan cell wall synthesis or lipid

biosynthesis. Degradation of mucin may provide the bacteria with an important carbon
source and allow it to conserve energy by absorbing glucosamine from the environment

rather than synthesizing the molecule itself from D-fructose-6-phosphate.
We tested the role of HNS in expression ofyghJ but found that HNS had no
influence over expression ofyghJ. We re-cloned the promoter region ofyghJ onto a
vector to form a transcriptional fusion but have not been able to demonstrate regulation to
date. We were surprised by our data since another group reported that yghJ plays a role in
transcription of the type II apparatus in ETEC. The yghJ gene in this species is located
upstream of the operon for type II secretion. In contrast, to our knowledge STEC
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091 :H21 does not possess the type II secretion operon. In the E. coli K12 background

yghJ is located on its own transcriptional unit separate from the pppA and glcA flanking
genes. Another report on EPEC strains shows that YghJ is secreted by the type II system

and is probably not involved in transcription of the type II secretion operon (Baldi et al.,
2012). Instead they suggest that YghJ is essential in formation of EPEC biofilm. The
yghJ null mutant they created was unable to successfully form biofilms under laboratory
conditions (Baldi et al., 2012). YghJ produced by STEC 091:H21 is not a secreted
protein.

We were unable to purify the YghJ protein and Western blot data indicated that

the 6XHis tag was not detectable by two separate antibodies. This may indicate that YghJ
possesses an undetected cleavage sequence on the carboxy-terminus of the protein or that

the protein possesses intramolecular bonds or is otherwise folded in a manner that renders
the His tag inaccessible. We are creating a His-tagged variant of the YghJ protein lacking
the signal sequence to determine if the protein can be purified from the cytoplasm maybe
then we can use metal chelate to purify the protein.

The Bacteroides thetaiotamicron enhancin-like protein/the M60-like protein is

also an inner membrane protein yet all the experiments shown in the Nakjang manuscript
the protein did not contain the signal sequence thereby re-directing it to the cytoplasm

(Nakjang et al., 2012). The Baldi group did not attempt purification but showed a protein

preparation from lysate and the Yang group never demonstrated expression of the protein
at all, although an RT-PCR did indicate transcription of the gene to mRNA. We suspect
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but can not prove that these groups could not isolate the YghJ by His-tag or Gst-tag
immunoaffinity purification methods.

There is strong evidence from our group and from other reports that the YghJ

protein holds great promise as a unique protein with a significant role in host
colonization. Looking forward we predict that L-malate utilization only one of the many
functions of YghJ.

In addition to studies to identify and characterize novel virulence factors, one of

my goals was to define the mechanism behind HNS repression of the enterohemolysin
operon. The enterohemolysin operon is a well-defined group of genes that have been
extensively studied by various groups yet its specific function in virulence of LEEnegative STEC is still unknown. However, previous data does suggest a role in the
disease process (Smith et al., 2008).

Defining the mechanism of HNS repression of the enterohemolysin operon

Both LEE-negative and LEE-positive STEC strains seem to tightly regulate the

expression of enterohemolysin. For example, reports indicate difficulty in detecting
liquid-phase hemolytic activity in culture supernatants recovered from isolates of Shiga
toxin-expressing E. coli (Beutin et al., 1989) (Chart et al., 1998) (Schmidt et al., 1995)
Moreover, contact hemolytic activity requires at least 16 hours incubation on blood agar
plates before hemolysis is detectable (Chart et al., 1998) (Schmidt et al., 1995). Data

presented here supports the idea that in STEC, transcription of the ehx operon is tightly
controlled by the global regulator HNS. Why would such tight restrictions be placed on
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expression of ehxAl We know that HNS is important for adequate adherence and
motility since null mutations in hns disrupt both of these function (Scott et al., 2003). A
recent animal study by (Smith et al., 2008) shows that a-hemolysin is the direct cause of
sloughing of epithelial cells from the urethral lining of mice within 24 hours post
bacterial inoculation. Thus a-hemolysin causes significant damage to the urethral
epithelial mucosa and contributes to disease manifestations of infection (Smith et al.,
2008). We suggest that a significant amount of EhxA present during the initial stages of
colonization when adherence is most important would be counter-productive. Therefore,

we propose that the reason EhxA is down-regulated at 37°C may be to allow bacterialhost cell attachment to occur without the risk of host cell damage by EhxA during

colonization. We now know that expression of enterohemolysin is repressed at 37°C but
we also know that at some point during infection EhxA must be made because

convalescent sera of patients that recover from STEC infections contain antibody to
EhxA (Schmidt et al., 1995). As of yet, the precise role of EhxA in STEC disease has not
been determined.

The HNS protein acts to silence or repress gene expression of several diverse and
unlinked genes in E. coli and other Gram-negative bacteria (Dorman, 2004;Dorman,
2007). It is thought that HNS binds to DNA and creates a nucleoprotein structure which

may be a blockade to RNA polymerase and repress transcription of specific genes
(Dorman, 2004;Dorman, 2006). The precise mechanism as to how HNS silences gene
transcription remains a debate (Dorman, 2004). This small 137 amino acid protein
contains a nucleic-acid binding domain at its carboxy-terminus attached by a flexible
105

linker to an oligomerization domain at its amino-terminal end. Investigation of binding of
HNS to DNA reveals that it does not typically bind to a specific consensus sequence but
binds to A + T-rich regions of curved DNA(Dorman, 2006). However, a study by Lang et
al 2007 identified a discrete DNA sequence, 5'-TCGATATATT-3', in a subset of genes
to which HNS bound (Lang et al., 2007). We have not found this specific DNA sequence
in the promoter region of ehxC.

Some A+ T-rich regions of DNA may be sensitive to environmental factors such
as osmolality and temperature. Changes in these factors can affect curvature of DNA at
the promoter of HNS regulated genes causing HNS to bind or to be displaced. Moreover,
HNS itself can also cause change in curvature of DNA at select promoters. The precise

environmental cues that stimulate binding of HNS to the cis-acting element upstream of
ehxC are not known. Also, factors that cause HNS to be displaced from the promoter

region have not been explored. Our studies show that HNS can bind to the promoter
region at both 25°C and 37°C which suggests that temperature may not play a large role
in regulation of ehx expression. Furthermore, during analysis of the in vivo effect of an

hns null mutation on the expression of ehx, we found that HNS was essential for
repression of transcription of ehx in E. coli cells grown to mid-log phase at 37°C. In
contrast, a study with an STEC 0157 isolate by Li et al. showed that HNS inhibition of

ehx was maximal when cultures were grown at 30 °C and had reached stationery phase
(Li et al., 2008). Our data are based on findings for LEE-negative STEC which probably
explains the discrepancy in the conclusions between our two groups.
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It is well documented that temperature and osmolality are environmental factors

that regulate expression of plasmid-encoded genes of the hlyCABD virulence operon
cloned from the transmissible plasmid pHlyl 52 carried by the extra-intestinal
uropathogenic E. coli strain PM152 (Juarez et al., 2000), (Madrid et al., 2002). HNS is a
crucial factor in regulation of the hly operon as it binds to two essential cis-acting
elements located upstream of the coding region of hlyCABD (Godessart et al., 1988)

(Vogel et al., 1988). In the case of hly, protein-protein interactions between HNS and the
small regulator protein Hha control expression of the hly operon in response to
environmental changes in osmolality and temperature (Nieto et al., 1991;Nieto et al.,
1997;Nieto et al., 2000). We found that there is no DNA sequence identity between the

osmo-thermoregulatory cis-acting elements found upstream of hlyCABD and the
promoter region of ehxCABD encoded by STEC 091 :H21 and STEC 0113 :H21.
It is widely accepted that the ehx operon is transcribed from a single promoter
located upstream of the ehxC gene (Schmidt et al., 1996) (Brunder et al., 2006) (Schmidt
et al., 1995) (Bauer and Welch, 1996). Sequence analysis of the ehx operon located on

the large 165 kbp plasmid of STEC Ol 13:H21 strain EH41 revealed that 302 nucleotides
lie between the stop codon of the previous open-reading-frame and the ATG start site of
the ehx operon (Leyton et al., 2003). By comparison, the STEC 0157:H7 Sakai strain

contains 564 bp of DNA upstream of the start of the open-reading-frame of ehxC
(Makino et al., 1998). When we compared the sequence of DNA 100 bp upstream of the
ehxC gene encoded by strain B2F1 to four different isolates of STEC 0157, we found
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that the DNA sequences were almost identical. We determined that HNS binds to the

same region of the putative ehx promoter in STEC 0157:H7 as in STEC 091 :H21. This
could indicate that the LEE was acquired by LEE positive STEC after the large virulence
plasmid, and that before acquisition of the LEE, the ehx operon was regulated by the
same mechanism in LEE positive and LEE negative strains.

Although regulation of the ehx operon carried by STEC isolates involves
activation by GrlA, we propose that HNS plays a significant role in ehx regulation. For
example, GrlR negatively regulates GrlA through direct interactions (Creasey et al.,

2003) (lyoda and Watanabe, 2005) (Jobichen et al., 2007). As STEC 0157:H7 organisms
reach stationary growth phase, concentration of the negative regulator GrlR drops with
increased levels of free GrlA as a result (lyoda and Watanabe, 2005). The GrlA protein is
then free to activate expression of ehx (Saitoh et al., 2008). We suggest that activation of
ehx by GrlA probably occurs through GrlA inhibition of HNS binding to the promoter
region of ehx thereby mitigating the repression of enterohemolysin by HNS. Disruption

of HNS repression by GrlA and the mechanism by which it is achieved remains to be
proven. However, several models exist in nature which involves displacement or
blockade of HNS (Stoebel et al., 2008). For example, in Vibrio cholerae the ToxT
regulatory protein silences HNS by displacement of HNS from the promoter of genes that
the ToxT regulator activates (Hulbert and Taylor, 2002) (Yu and DiRita, 2002).
In this study, we showed that transcriptional control of the ehx operon by HNS is
due to binding of HNS within an 88 bp region of DNA located upstream of the
108

translational start codon of ehxC. Previously, we found that HNS played a role in ehxA

gene expression (Scott et al., 2003) but it was not known until now that HNS binds to cisacting elements within the promoter region to directly repress expression of ehxCABD in
STEC 091 :H21. We also show that the almost identical nucleotide sequence within the

promoter region of both LEE-negative and LEE-positive STEC is bound by HNS in the
same manner. In the future the specific nucleotides involved in HNS inhibition of the ehx

operon will be identified. Evidence indicates that HNS regulation occurs in LEE-negative
STEC serotypes through direct DNA-binding to promoter DNA sequences.
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